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4 Introduction
1.1 Breast cancer screening
Breast cancer is the most frequently diagnosed cancer among women, worldwide1. In
2012, 464 000 new cases (13.5% of all cancers) were diagnosed in Europe and 131 000
died from the disease2. It is known that survival rate is associated with the stage of
the detected cancer. If breast cancer is detected early, chances for survival increase due
to more eﬀective treatment, and quality of life of patients decreases less because early
detection enables less radical surgery and restrictive use of radiation therapy.
Many countries have introduced breast cancer screening programs to beneﬁt from
early breast cancer detection. In regular breast cancer screening programs, asymp-
tomatic women are periodically invited for a mammographic examination. Several
studies showed that breast cancer screening by mammography reduces breast cancer
mortality in women over age 50 by 25-30%3,4. However, mammography has its limita-
tions as its sensitivity is severely impaired in women with dense breasts. The reason is
that dense tissues (ﬁbroglandular and stromal tissues) and breast cancer appear both
equally bright on mammographic images as they have the same or similar x-ray atten-
uation properties. As a result, the risk of missing breast cancer in screening programs
while they are still in an early stage of development is increased5–9. In addition, women
with dense breasts have a risk of breast cancer four to six times higher than women
with no or little dense tissue10.
Personalized, tailored screening programs have been proposed to improve breast
cancer detection in women with dense breasts and other risk factors for developing
breast cancer11,12. Those risk factors which are associated with increased risk are
family history of breast cancer and the presence of a germ-line mutation of the BRCA1
or the BRCA2 gene13,14. In these personalized screening programs, these high risk
populations can be screened with a complementary modality, such as ultrasound or
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI). American15
and European16 Cancer Societies guidelines recommend the use of DCE-MRI as a
complementary imaging modality for women with cumulative lifetime breast cancer
risk of more than 20-25%. Other indications for DCE-MRI include, but are not limited
to, preoperative staging, evaluation of women treated with neoadjuvant chemotherapy
and problem solving in case of inconclusive ﬁndings from other modalities.
Compared to mammography, breast DCE-MRI presents higher sensitivity17–22, es-
pecially in women with dense breasts23. However, speciﬁcity is more variable, both
for screening16 and characterization24 purposes, since the examination of breast DCE-
MRI depends on many factors such as reader expertise and use of adequate visualization
techniques. Another limitation of breast MRI is that its analysis requires interpreta-
tion of four-dimensional DCE data, as well as correlation to multi-parametric data from
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other MRI imaging sequences, and is therefore a time consuming task. Furthermore,
recent studies reported potential observer errors such as misinterpretation or oversight
of breast cancer lesions that were visible on a follow-up or incident round of screening
MRI25,26.
Automated image analysis techniques and Computer-Aided Detection (CAD) sys-
tems can be used in order to aid radiologists in reading and interpreting MRI images.
This thesis focuses on the investigation of image analysis techniques for the automated
interpretation of breast DCE-MRI images.
1.2 DCE-MRI of the breast
An example of an MRI scanner is shown in Fig. 1.1. An MRI system consists of the
following components:
• A large magnet to generate the magnetic ﬁeld and shim coils to make the magnetic
ﬁeld as homogeneous as possible. This magnetic ﬁeld aligns the hydrogen nuclei
of the body parts being imaged.
• A radio-frequency (RF) coil to transmit a radio signal into the body part being
imaged. This radio signal is applied after aligning the hydrogen nuclei with the
high magnetic ﬁeld.
• A receiver coil to detect the returning radio signals due to the nuclei relaxation.
• Gradient coils to provide spatial localization of the signals applying additional
magnetic ﬁelds. These additional magnetic ﬁelds can be used to only generate
detectable signal from speciﬁc locations in the body (spatial excitation) and/or to
make magnetization at diﬀerent spatial locations process at diﬀerent frequencies,
which enables 𝑘-space encoding of spatial information.
• A computer to reconstruct the radio signal into the ﬁnal image (usually by means
of Fourier transforms).
The voxel intensity of an MR image is determined by four basic parameters: proton
density, T1 relaxation time, T2 relaxation time, and ﬂow. Proton density is the con-
centration of protons in the tissue in the form of water and macromolecules (proteins,
fat, etc.). The T1 and T2 relaxation times deﬁne the way the protons revert back to
their resting states after the initial RF pulse. The most common eﬀect of ﬂow is loss
of signal from rapidly ﬂowing arterial blood.
The signal intensity contrast in an MR image can be manipulated by changing the
pulse sequence parameters. A pulse sequence sets the speciﬁc number, strength, and
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Figure 1.1: Siemens 3T MRI scanner. Image from www.healthcare.siemens.com.
timing of the RF and gradient pulses. The two most important parameters are the
repetition time (TR) and the echo time (TE). The TR is the time between consecutive
RF pulses. The TE is the time between the initial RF pulse and the echo.
The most common pulse sequences are the T1-weighted and T2-weighted spin-echo
sequences. The T1-weighted sequence uses a short TR and a short TE (TR < 1000
msec, TE < 30 msec). The T2-weighted sequence uses a long TR and a long TE (TR
> 2000 msec, TE > 80 msec).
Dynamic contrast-enhanced magnetic resonance imaging of the breast is most com-
monly performed as a combination of several T1-weighted MR image acquisitions over
time following contrast agent injection. MRI has several types of contrast agents usu-
ally containing paramagnetic metals. The most common type of these agents is the
gadolinium chelates. Cancer tends to be a relatively rapid growing tissue needing lots
of nutrients and oxygen. This causes cancer cells to stimulate blood vessel growth.
The increased vascularity and permeability of the blood vessels causes contrast agent
to diﬀuse out into cancerous tissue more easily than into normal tissue, resulting in
higher concentrations and thus higher signal intensity on T1-weighted sequences.
Figure 1.2 shows a graphical representation of the DCE-MRI acquisition process.
As stated in the European breast MRI guidelines16, a dynamic sequence demands at
least 3 times points to be measured: one before the administration of the contrast
medium, one approximately 2 min later to capture the peak and one in the late phase
to evaluate whether a lesions continues to enhance (persistent), shows plateau or show
early washout of the contrast agent. The time course of the signal intensity enhancement
over the lesion is of important diagnostic value as demonstrated by Kuhl et al.27.
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The optimal number of repetitions is unknown, but 4 or 5 post contrast acquisitions,
with data acquisition times in the order of 60 - 120 sec per volume acquisition, are
commonly performed in current clinical practice. DCE-MRI of the breast also requires
a high spatial resolution with voxel size under 2.5 mm in any direction to be capable of
detecting all lesions larger than or equal to 5 mm. During the acquisition process, the
patient is placed in prone position. A dedicated bilateral breast coil (see Fig. 1.3) is
used. It is also important to mention that, in pre-menopausal women, it is essential to
perform breast MRI in the correct phase of the menstrual cycle as enhancing normal
breast tissue may otherwise complicate the interpretation of the study25,28.
Figure 1.2: Breast DCE-MRI acquisition scheme. Several volumes are acquired before (V0) and after
(V1−𝑁) contrast agent injection. Signal enhancement computed over the region of the lesion can be
classiﬁed as persistent (green), plateau (blue) and early washout (red).
(a) (b)
Figure 1.3: (a) Dedicated bilateral breast coil. (b) Patient is placed in prone position with both breasts
hanging in the coil loops. Images from www.healthcare.siemens.com.
For diagnostic interpretation of breast lesions, T1-weighted images and subtracted
images and their maximum intensity projection for all the available times points are
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analyzed (see Fig. 1.4). Morphological and kinetic information (curve type) of the
breast lesions are assessed according to the ACR Breast Imaging and Data System
(BI-RADS) breast MRI lexicon29.
(a)
(b)
(c)
Figure 1.4: (a) Axial slice of the pre-contrast T1-weighted volume and (b) corresponding axial slice
extracted from the subtraction volume computed at the ﬁrst post contrast time point. Maximum
intensity projection image of the subtracted volume is shown in (c).
1.3 Current clinical use of computer assistance
In current clinical practice, dedicated workstations are used to assist the radiologist in
detection and classiﬁcation of breast lesions in DCE-MRI data. These systems visualize
a single DCE-MRI study by displaying T1-weighted, subtracted and maximum intensity
projection images of all the available times points of a desired region in addition to the
kinetic curve. Moreover, these dedicated workstations provide an automated kinetic
assessment by color-coding the intensity changes per voxel during enhancement of the
breast tissue. The visualization of the images combined with this automated assessment
aid in the interpretation of patterns of contrast enhancement (persistent, plateau and
washout enhancement) across a series of MRI volumes30. However, human interaction
is still required to identify and characterize suspicious areas in four-dimensional data.
Therefore, interpretation of breast DCE-MRI is still a time consuming task. Human
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interaction increases the risk of misinterpreting or overlooking breast lesions25,26 and
may cause inter- and intra-observer variability31.
Due to these limitations, there is still the need to develop automated image analysis
tools and computer-aided detection systems to aid in the interpretation of DCE-MRI
of the breast. These automated techniques have the potential to decrease the workload
of radiologists and improve the diagnosis. In screening mammography, computer-aided
detection systems have been considered as a tool to relieve the shortage of trained
readers for double reading32,33. These systems can also be used as an aid to help the
ﬁrst reader localizing the abnormality more quickly and more accurately, suppressing
the chance that lesions are overlooked by radiologists due to fatigue or lack of experience.
Diﬀerent studies34–37 have shown that use of CAD can improve reader performance of
breast cancer detection or screening. In the USA, the majority of mammograms are
nowadays read with CAD support.
CAD systems for breast DCE-MRI are being developed38–40. These CAD systems
follow a similar pipeline composed of motion artifacts correction, breast segmentation,
voxel candidate detection and regional candidate detection analysis. However, they are
still in an initial stage of development and, therefore, further research is required to
improve each of these automated image analysis steps that are not easy tasks on their
own. For instance, some authors focused on automated segmentation of the breast41,42,
which requires the delineation of the chest wall and the boundary between breast and
background (or air). This is a diﬃcult task due to the large shape variations across
patients. Another complicating factor that stands in the way of any image processing
application is the MR signal intensity variability from patient to patient due to diﬀer-
ences in size and anatomy of each patient, the use of diﬀerent acquisition parameters
and/or the eﬀect of image inhomogeneities.
The development of automated image analysis techniques is also important for their
use in other applications that can improve the clinical outcome in breast MRI. Auto-
matic linkage of current and prior examinations43, breast density estimation in breast
MRI44 and automated breast MRI quality assessment are some examples.
1.4 Thesis outline
This thesis describes methods for quantitative analysis of magnetic resonance imaging of
the breast. The main focus is breast density estimation, as dense tissue has been related
to the risk of breast cancer development, and automated lesion detection to aid in the
interpretation of DCE-MRI of the breast. Other techniques have also been developed
to serve the main goal including image normalization, pectoral muscle segmentation
and breast segmentation, among others.
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The outline of this thesis is as follows. Chapter 2 provides two automated pectoral
muscle segmentation methods. The delineation of the pectoral muscle is essential to
segment the breast. In particular, we investigated the performance and complexity
of two novel atlas-based methods for pectoral muscle segmentation in breast MRI.
Chapter 3 presents a fully automatic approach to segment the breast and estimate
breast density. Other image analysis techniques such as image normalization are also
described. In chapter 4, a method for measuring volumetric breast tissue estimates from
digital mammograms45,46 is validated by comparing its results to volume estimates that
were obtained from breast MRI data. The volumetric estimates fromMRI were obtained
using an improved version of the method described in chapter 3. Chapter 5 describes a
CAD system for the automatic detection of breast cancer. In chapter 6, the potential
of the CAD system to detect breast cancer which was overlooked or misinterpreted by
a radiologist in a breast screening program with MRI is investigated. The thesis will
be ﬁnalized with a summary and discussion chapter.
Segmentation of the pectoral muscle in breast
MRI
2
Albert Gubern-Mérida, Michiel Kallenberg, Robert Martí, Nico Karssemeijer
Original title: Segmentation of the pectoral muscle in breast MRI using atlas-based
approaches
Published in: Lecture notes in computer science (2012); 7511(1):371–378
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Abstract
Pectoral muscle segmentation is an important step in automatic breast image analysis
methods and crucial for multi-modal image registration. In breast MRI, accurate de-
lineation of the pectoral is important for volumetric breast density estimation and for
pharmacokinetic analysis of dynamic contrast enhancement. In this paper we propose
and study the performance of atlas-based segmentation methods evaluating two fully
automatic breast MRI dedicated strategies on a set of 27 manually segmented MR vol-
umes. One uses a probabilistic model and the other is a multi-atlas registration based
approach. The multi-atlas approach performed slightly better, with an average Dice
coeﬃcient (DSC) of 0.74, while with the much faster probabilistic method a DSC of
0.72 was obtained.
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2.1 Introduction
Automatic identiﬁcation of pectoral muscle is an important step in methods for auto-
matic breast cancer assessment in most image modalities. For instance, in mammogra-
phy, the most used image modality in screening programs, the detection and removal
of the pectoral muscle is often used to remove false positive marks of Computer Aided
Detection (CAD) systems47. In Magnetic Resonance Imaging (MRI) of the breast, the
image modality employed in the presented work, the importance of the pectoral muscle
detection has recently been recognized in two applications. Firstly, breast tissue density
has been identiﬁed as an important risk factor for developing breast cancer, being four
times larger in women with a breast density higher than 75%, compared to those with
little or no density7. Breast MRI provides a good tissue contrast between ﬁbroglan-
dular and fatty tissues and a three-dimensional characterization of breast composition.
These good properties in the breast tissue have been a strong reason to use breast MRI
in breast density measurement48–50. However, the contrast between pectoral muscle
and dense tissue is poor. Hence, a ﬁrst step to separate the breast from the body is
commonly essential. This separation is not trivial due to the large shape and intensity
variations in the pectoral muscle of diﬀerent patients. Some solutions are present in
the literature: boundary tracing or spline ﬁtting without51 and with manual interven-
tion48,49 and delineation of the whole breast using breast models52, but none of them
completely delineates the pectoral muscle.
Secondly, MRI is often used with a contrast agent for lesion detection. For a better
interpretation of contrast enhancement lesions, researchers have tried to incorporate
pharmacokinetic modeling to the interpretation of the MRI. Some of these models
require calibrations with respect to reference tissues and make use of the signal intensity
of speciﬁc regions for determining physiological measures53. In breast MRI, the pectoral
muscle can be used as a reference tissue given its properties.
Atlas-based segmentation has been shown to be a powerful technique for automatic
delineation of anatomical structures in diﬀerent 3D image modalities54,55. Multi-atlas
and probabilistic approaches are the most commonly used strategies. By deﬁnition,
the former is supposed to obtain more precise segmentations than the latter. How-
ever, multi-atlas approach is far more time consuming. There has been only one initial
attempt that uses an atlas strategy for breast MRI segmentation50, but the segmen-
tation of the pectoral muscle was not the main interest of the work. Moreover, the
method followed a probabilistic approach using one reference atlas, which could have
some limitations. As shapes are highly variable, the reference choice aﬀects ﬁnal results.
The novelty of this paper consists in the study of fully automatic atlas-based meth-
ods for pectoral muscle segmentation in breast MRI in terms of performance and com-
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plexity. A dedicated multi-atlas approach based on Klein et al.55 is proposed (see
section 2.3.3) and compared to the probabilistic approach of Gubern-Mérida et al.50
(see section 2.3.2). An original breast MRI registration framework focused on the body
has been also deﬁned and used in both methods (see section 2.3.1). To our knowledge,
no similar studies are found in the literature. Advantages and inconveniences of both
strategies are discussed in sections 2.4 and 2.5 and a solution to obtain a reasonable
time-accuracy trade-oﬀ is proposed.
2.2 Material
The data set used to evaluate the segmentation results and build the atlases consists of
27 pre-contrast T1-weighted MR breast scans obtained from diﬀerent patients. Breast
MRI examinations were performed on a 1.5 T system (Siemens 1.5T, Magnetom Vision),
with a dedicated breast coil (CP Breast Array, Siemens, Erlangen). The pixel spacing
diﬀered between volumes with values ranging from 0.625 mm to 0.722 mm. The slice
thickness was 1.3 mm and the volume size was 512 x 256 x 120 voxels. Patients were
scanned in prone position.
Three experienced observers performed manual segmentations. Two of them manu-
ally segmented only the pectoral muscles of 8 cases. The third one manually segmented
each of the 27 MR volumes into 7 classes: background, fatty tissue, glandular tissue, pec-
toral muscles, lung area and the heart. The seventh class is the ”other” class and refers
the previous non-labeled voxels of the thorax. Annotations were done every 5-10 slices
and linear interpolation was applied to obtain the complete labeling. When needed,
and especially for heart, lungs and pectoral muscles, accurate manual delineation was
performed with a smaller slice interval. For the manual segmentation of background,
fatty and ﬁbroglandular tissue, thresholding was applied over regions of interest pro-
vided by the reader. Fig. 2.1 shows an example of a MRI slice on an axial view and
the manual delineation of the mentioned classes. One should note the complexity of
performing such ground truth annotations, where each volume takes approximately 45
minutes in a dedicated breast MRI annotation environment.
Figure 2.1: Breast MR scan on an axial slice with the manual annotation of the diﬀerent structures.
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2.3 Methods
Atlas-based strategies are characterized by the use of prelabeled images, usually manu-
ally obtained, to perform the automatic segmentation of new images, also called targets.
They employ registration algorithms, which play an important role for the ﬁnal seg-
mentation. Section 2.3.1 explains the mapping algorithm used by the two atlas-based
approaches evaluated in this paper. Section 2.3.2 brieﬂy describes the construction and
the use of a probabilistic atlas in a Bayesian framework segmentation50. Finally, in sec-
tion 2.3.3 we report the proposed multi-atlas segmentation algorithm for the delineation
of the pectoral muscle in breast MRI.
2.3.1 Registration
Registration is an important step in atlas-based segmentation algorithms. Without an
accurate transformation between the structures we aim to segment, the segmentation
can not perform accurately. For this reason we developed a registration framework
focused on the body area. We observed that the sternum is always localized between
pectoral muscles. Hence, by accurately localizing the sternum the pectoral muscles can
be aligned. Our registration approach is initialized by detecting the sternum of the
subjects. Automatic sternum detection is described in Sec. 3.2.1 of this thesis. Then,
the volumes are cropped at 2 cm distance anterior to the sternum position to focus the
registration on the area of the body. By doing so, most breast tissue is removed and can
not negatively bias the ﬁnal mapping of body structures. The 2 cm distance anterior
to the sternum ensures that pectoral muscle voxels are not discarded.
The registration process is composed by two stages. First, a translation transform
is performed, where translation along the 𝑦 axis is deﬁned by the distance between
𝑦-coordinates of both sternums. Translation along 𝑥 and 𝑧 axis is found by optimizing
the similarity measure. The second stage is a non-rigid transform based on B-Splines
registration in a multi-resolution scheme using a stochastic gradient descent optimizer.
Three resolutions were deﬁned. B-Splines grid spacing was set to 32, 16 and 8 mm for
each of the resolutions taking the size of the pectoral muscle into account. The similarity
measure maximized by the whole framework was normalized cross correlation (NCC)
as all the datasets were acquired with the same modality. Elastix56 was used for the
implementation.
2.3.2 Method 1: Probabilistic atlas-based segmentation
In the presented atlas-based segmentation method, a probabilistic atlas is used in a
Bayesian framework to provide an accurate probability distribution for the pectoral and
the thoracic area. Following a leave-one-out evaluation strategy, for the segmentation of
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each patient, a full probabilistic atlas was built oﬄine with the 26 remaining patients.
These 26 patients and their segmentations were mapped using the registration method
explained previously into the same reference space. The probabilistic atlas was created
by computing the frequency with which each location was labeled as a speciﬁc organ. A
common reference space was used for all the experiments by visually selecting an extra
patient which has normal appearance. The reference case, or anatomical image of the
atlas, was not included in the evaluation set.
Figure 2.2: Probabilistic atlas segmentation approach overview.
Figure 2.2 shows the general schema of the segmentation framework with Bayesian
voxel classiﬁcation algorithm incorporating the use of the probabilistic atlas. From top
to bottom, the probabilities of the atlas are mapped by registration of section 2.3.1 onto
target image space {T} using the anatomical image of the atlas. The probabilistic atlas,
the tissue models (previously built from the scans and manual segmentations of the
data set) and the target are provided to the Bayesian framework as a prior probability
𝑃(𝑋), conditional probability 𝑃(𝑌 |𝑋) and set of intensity values 𝑌 , respectively. The
Bayesian framework estimates the segmentation 𝑋 that maximizes 𝑃(𝑋)𝑃(𝑌 |𝑋) and
also includes a Markov Random Field (MRF) regularization to smooth the segmentation
taking neighborhood information into account50.
2.3.3 Method 2: Multi-atlas segmentation
Multi-atlas segmentation approaches consider all the volumes of the dataset and their
manual segmentations as individual atlases. The term atlas is deﬁned as the pair of the
anatomical image (MRI volume) and its manual segmentation or label. The process to
obtain an automatic segmentation for a target volume is illustrated in ﬁgure 2.3. First,
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given the target volume 𝑇 , all the atlases are mapped onto the target space using the
registration algorithm of section 2.3.1. Subsequently, the deformed anatomical images
are compared to the target to perform a selection of the most similar atlases. The
selection is based on the Normalized Cross Correlation similarity measure and a ratio
deﬁned as follows:
𝑟𝑖 =
𝑁𝐶𝐶(𝑇 ,𝐴𝑖 ∘ 𝑀𝑖)
𝑚𝑎𝑥𝑗𝑁𝐶𝐶(𝑇 ,𝐴𝑗 ∘ 𝑀𝑗)
, (2.1)
where 𝑀 refers to the mapping between the target and an atlas and 𝑗 refers to the
deformed atlas with maximum similarity. An atlas 𝐴𝑖 is selected if it satisﬁes 𝑟𝑖 ≥ 𝜑.
A value of 𝜑 = 0.9 empirically appeared to be the best value for our results.
Figure 2.3: Multi-atlas segmentation approach overview.
Finally, the selected deformed atlas labels are fused to yield a single ﬁnal segmenta-
tion of the patient or target image. This step is called decision fusion and deﬁnes how
the deformed segmentations of the selected atlas are combined. In this work we have
made use of majority voting method, which was proven to give good results in55.
2.4 Results
In a leave-one-out experiment we evaluated the probabilistic and the multi-atlas seg-
mentation frameworks on 27 patients. Each segmented case was not included for the
construction of the probabilistic atlas or within the set of individual atlases respec-
tively. The quality of the segmentation was measured by determining the similarity of
the segmentation with the ground truth using the Dice Similarity Coeﬃcient (DSC).
DSC was chosen as it is commonly used in the literature50,55. For all cases we manually
discarded initial and last slices which do no contain relevant information or are clearly
aﬀected by noise. Figure 2.4(a) shows a box plot with DSC values for each method.
Segmentation results are similar (DSC median of 0.76 for both and DSC mean ± sd of
0.72 ± 0.09 and 0.74 ± 0.06 for probabilistic and multi-atlas respectively), but multi-
atlas framework slightly outperforms the probabilistic. These results can be better seen
in ﬁgure 2.4(b), where DSC values of each case using both methods are shown.
Lower DSC values are mainly due to the registration process not being able to
compensate the diﬀerences between volumes. This is more the case of the probabilistic
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Figure 2.4: (a) Box plot with segmentation DSC for pectoral segmentation and (b) DSC segmentation
results for each of the 27 cases using probabilistic (P) and multi-atlas (M) approaches.
Figure 2.5: Intermediate slices from 3 diﬀerent cases and their segmentations.
approach as the method uses only one registration with a single reference. In those
cases (see case 7 for instance), the multi-atlas approach performs better as it includes
multiple registrations and selects the best ones. Only in one case (number 20) the
probabilistic approach obtains results much better than multi-atlas, where pectoral
muscle segmentation in initial slices is not really precise (labeled as thorax instead).
However, accurate delineations in intermediate slices are obtained for both methods as it
is illustrated in ﬁgure 2.5, where three examples of automatic and manual segmentations
are shown.
Finally, since no previous works performed pectoral segmentation in breast MRI,
inter-observer variability was computed by 3 viewers over 8 manual segmentations.
DSC mean of 0.70 ± 0.12 and median of 0.72 were obtained, lower than the DSC values
achieved by the automatic atlas-based approaches.
All the tests have been launched on Intel(R) Core(TM)2 Quad CPU Q9550 2.83GHz.
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Starting with the common step, registration between two volumes takes 𝑡𝑟 ≈ 12 min.
The complexity time for multi-atlas segmentation is explained as 𝑡𝑚𝑢𝑙𝑡𝑖−𝑎𝑡𝑙𝑎𝑠 ≈ 𝑁 ×
(𝑡𝑟 + 𝑡𝑎) + 𝑛 × 𝑡𝑓 , where 𝑁 is the number of individual atlases (𝑁 = 26), 𝑡𝑎 the
time to compute the mapping and the comparison of an individual anatomical atlas
(𝑡𝑎 ≈ 4 min.), 𝑛 the number of selected atlases and 𝑡𝑓 the time to propagate and fuse
an atlas labeled image (𝑡𝑓 ≈ 3 min.). In the best scenario, being only one atlas selected
(𝑛 = 1), the computation time to obtain a segmentation using a multi-atlas approach
is 𝑡𝑚𝑢𝑙𝑡𝑖−𝑎𝑡𝑙𝑎𝑠 ≈ 419 minutes (7 hours). The complexity time for the probabilistic
approach is deﬁned as 𝑡𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑠𝑡𝑖𝑐 ≈ 𝑡𝑟 + 𝑡𝑝 + 𝑡𝑏, where 𝑡𝑝 is the time to map the
probability distributions to the target space (𝑡𝑝 ≈ 8 min) and 𝑡𝑏 the time to perform the
segmentation based on Bayesian theory (𝑡𝑏 ≈ 10 min). Approximately, 𝑡𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑠𝑡𝑖𝑐 ≈
30 min.
2.5 Discussion
In this work, the atlas-based methodology has been studied to perform the complete
delineation of the pectoral muscle in breast MRI, which has not been done previously.
Fully automatic and dedicated multi-atlas and probabilistic frameworks have been pro-
posed and tested on 27 diﬀerent patients.
The obtained results are satisfactory in both frameworks, with DSC values higher
than the computed inter-observer variability. It proves the high reliability of atlas-based
segmentation methods to perform pectoral delineations. However, we are aware that
the evaluation and the construction of the atlases were performed with annotations from
a single viewer, as obtaining 3-dimensional manual segmentations is a time consuming
task. The low inter-observer DSC value explains the diﬃculty and subjectivity to
delineate the pectoral muscle. Its shape has high-variability and cartilage, intercostal
muscles and fatty tissue also appear in the area. The inclusion of these tissues depends
on the observer opinion.
As it was expected, multi-atlas segmentation appears to be more consistent than the
probabilistic. This is explained by the fact that the multi-atlas approach includes an
atlas selection step to choose the most similar atlas compared to the segmented volume.
In the probabilistic framework, when the target diﬀers considerably from the reference
atlas and the registration can not compensate the diﬀerences, the ﬁnal segmentation
becomes aﬀected with slightly poorer results. However, the computation time for a
multi-atlas segmentation is 14 times larger.
Considering the inﬂuence of atlas selection, in future work we will study a multi-
probabilistic atlas framework. A larger dataset will be created with annotations from
diﬀerent observers. We will group diﬀerent breast MRI populations based on shape.
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For each population, a probabilistic atlas will be built. The most similar atlas to the
image at hand will be chosen for segmentation.
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Abstract
Breast density measurement is an important aspect in breast cancer diagnosis as dense
tissue has been related to the risk of breast cancer development. The purpose of this
study is to develop a method to automatically compute breast density in breast Mag-
netic Resonance Imaging (MRI). The framework is a combination of image processing
techniques to segment breast and ﬁbroglandular tissue. Intra- and inter-patient signal
intensity variability is initially corrected. The breast is segmented by automatically
detecting body-breast and air-breast surfaces. Subsequently, ﬁbroglandular tissue is
segmented in the breast area using Expectation-Maximization. A data set of 50 cases
with manual segmentations was used for evaluation. Dice Similarity Coeﬃcient (DSC),
total overlap, False Negative Fraction (FNF) and False Positive Fraction (FPF) are
used to report similarity between automatic and manual segmentations. For breast
segmentation, the proposed approach obtained DSC, total overlap, FNF and FPF val-
ues of 0.94, 0.96, 0.04 and 0.07, respectively. For ﬁbroglandular tissue segmentation,
we obtained DSC, total overlap, FNF and FPF values of 0.80, 0.85, 0.15 and 0.22,
respectively. The method is relevant for researchers investigating breast density as a
risk factor for breast cancer and all the described steps can be also applied in computer
aided diagnosis systems.
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3.1 Introduction
Breast Magnetic Ressonance Imaging (MRI) is a technique employed for (1) screen-
ing for breast cancer in high risk patients, (2) evaluation of tumor extent in speciﬁc
groups of patients with breast cancer (e.g. patients with invasive lobular carcinoma),
(3) evaluation of tumor response to chemotherapy treatment and, (4) trouble shoot-
ing in case of inconclusive ﬁndings from other modalities16. It provides good tissue
contrast between ﬁbroglandular (also referred to as dense) and fatty tissues, thus al-
lowing three-dimensional characterization of breast composition. Segmentation of the
diﬀerent structures visible in a breast MRI is needed to perform an automatic analysis
of such images. Some examples of applications in breast MRI which require an initial
segmentation step are multi-modal breast image registration, computer aided analysis
of dynamic contrast enhanced MRI57, and breast density assessment7,58. Related to
the latter, breast density has been identiﬁed as an important risk factor for developing
breast cancer, with risk being four times larger in women with a breast density higher
than 75%, compared to those with little or no density7,58. Automated segmentation of
breast density in breast MRI is the main focus of this work.
In general two steps are required to obtain 3D breast density measurement from
MRI: Breast segmentation and ﬁbroglandular tissue segmentation. The segmentation
of the breast is initially performed to exclude other tissue that does not belong to
the breast, such as pectoral muscle. The separation of the breast from the body is a
diﬃcult task. Complicating factors are the large shape variations of pectoral muscles
across diﬀerent patients and the similarity between intensity distributions of the MRI
signal in muscle and ﬁbroglandular tissues. Other issues are caused by the lack of
agreement on the anatomical extent of the breast. Because no automated segmentation
method was available, manual intervention has been mostly required44,49,59–61 in the
literature. In some studies the deﬁnition of the breast-body interface was made by
manually deﬁning a straight line59,60. Other studies combined edge detection ﬁlters and
manual outlining to delineate the breast volume49,61,62. Nie et al.44 used an approach for
breast volume segmentation that also requires some manual intervention when the chest
wall is connected to ﬁbroglandular tissue. Their algorithm starts with the detection
of body landmarks and is followed by Fuzzy C-Means (FCM), B-spline ﬁtting and
dynamic searching. However, the thoracic spine, which is used as a body landmark,
is not always visible in all acquisition orientations and ﬁeld of views. Fully automatic
breast segmentation has been addressed by a few authors. Wang et al.41 used second
derivative information represented by the Hessian matrix to delineate chest wall and
air-breast boundary. Another example is found in the work of Gallego-Ortiz et al.42,
where a method based on 3D edge detection combined with probabilistic atlas of the
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breast is proposed to extract the breast. Both approaches led to satisfactory breast
segmentation results, but segmentation of internal structures in the breast, such as
ﬁbroglandular tissue, was not included.
Regarding the second step, diﬀerent techniques have been applied to segment the
ﬁbroglandular tissue in breast MRI. Interactive thresholding of the breast tissue signal
intensity was used to study the correlation between MRI percent density and area-
based59,62 and volume-based60 mammography percent density. Alternatively, other
studies proposed a two-compartmental model61, which linearly combines pure-tissue
signals, and FCM algorithm44,49,63 to segment fatty and ﬁbroglandular tissue. More
recently, an atlas-aided probabilistic model-based method has been also described64,
where breast tissue is characterized by a mixture model and a ﬁbroglandular tissue prob-
abilistic atlas is used as a prior likelihood in combination with FCM. Among all these
studies on breast density estimation on MRI, only Wu et al.63,64 presented two fully
automatic ﬁbroglandular segmentation approaches integrated with automated breast
segmentation. In both approaches, the outline of the breast is initially deﬁned on each
slice of the MR volume using context information. In one approach63, the segmentation
of ﬁbroglandular tissue is performed using 2D FCM-alone. In the other method64, prior
learned ﬁbroglandular tissue likelihood is incorporated to FCM to segment ﬁbroglan-
dular tissue. A weak point of these fully automatic approaches is that the employed
breast and ﬁbroglandular tissue segmentation algorithms are 2D segmentation methods
which are applied to MR volumes on a slice-by-slice basis.
In this work, we present a framework that takes into account the 3-dimensionality
nature of breast MRI to automatically segment breast and ﬁbroglandular tissue. In
combination, these can be used for automated breast density estimation, which re-
quires computation of the relative amount of ﬁbroglandular tissue in the breast. The
framework consists of diﬀerent image processing steps. Firstly, signal intensity inho-
mogeneities are corrected. Subsequently, a 3D probabilistic atlas-based approach65,
previously used for pectoral muscle segmentation, is applied to segment the breast.
The Expectation-Maximization (EM) algorithm66 is ﬁnally used to estimate the image
intensity distributions of breast tissue and automatically discriminate between fatty
and ﬁbroglandular tissue. The novel contribution of the paper is to extend the work
presented by Gubern-Mérida et al.65 for breast segmentation and breast density esti-
mation in breast MRI. Breast segmentation step is evaluated with 27 MRI cases fully
annotated by an experienced observer. The ﬁbroglandular tissue segmentation step,
the ﬁnal aim of this work, is evaluated with 50 MRI cases compared to the annotations
provided by 4 diﬀerent observers.
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A general overview of the process to estimate the breast density segmentation is shown
in Fig. 3.1. Three preprocessing algorithms are initially applied: ﬁrstly, image inhomo-
geneities are corrected using the N3 bias ﬁeld correction algorithm67 to correct signal
intensity variations within the same structure of one speciﬁc case. The N3 is a non-
parametric method which was designed to be applied on early stages of automated data
analysis and does not require a model of the tissue intensities. Secondly, the sternum
is detected, which is used as an important landmark in diﬀerent parts of our algorithm.
Thirdly, intensities of the MR images are normalized to compensate for inter-patient
signal intensity variability.
The segmentation starts separating the body from the breast. The body consists
of lungs, heart, pectoral muscle, thoracic area and fat outside the base of the breast.
The breast is connected to the pectoral muscle and is composed by fatty and dense
tissues68. A probabilistic atlas, which contains spatial information of pectoral muscle,
lungs, heart, thorax and breast tissue, is used to exclude the body from the breast65.
Finally, the breast volume is deﬁned and the dense tissue is delineated using the EM
algorithm. Each step is sequentially presented in the following sections.
Figure 3.1: General overview of the process for dense tissue segmentation in breast MRI.
3.2.1 Sternum landmark detection
The sternum is a bone localized between pectoral muscles and is always visible in
centered axial slices. The use of a breast coil ensures that the sternum is roughly in
the center of the image. We consider the sternum as an important landmark to guide
the separation between body and breast (see Fig. 3.2(a)) and we use the 𝑦-coordinate
of the outer edge of the sternum in two stages of our method.
To detect the outer edge of the sternum, we observed that the pectoral muscle
border appears as the surface with the strongest edges in the image with maximum
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positive gradient in 𝑦 direction, using the coordinate system deﬁned in Fig. 3.2. Taking
advantage of this observation we implemented a ﬁrst-derivative-based ﬁlter to enhance
this edge and detect the sternum landmark point. Note that throughout this paper
a voxel position is noted as a 3-dimensional vector 𝑟 with components 𝑟𝑥, 𝑟𝑦 and 𝑟𝑧.
Given an MR image 𝐼(𝑟), the ﬁrst derivative volumes 𝐼′𝑥(𝑟) = 𝛿𝛿𝑥𝐺𝜎1(𝐼(𝑟)), 𝐼
′
𝑦(𝑟) =
𝛿
𝛿𝑦𝐺𝜎2(𝐼(𝑟)), 𝐼
′
𝑧(𝑟) = 𝛿𝛿𝑧𝐺𝜎3(𝐼(𝑟)) are computed in each direction at diﬀerent Gaussian
scales: 𝜎1 = 𝜎3 = 5 mm and 𝜎2 = 1 mm. The output of the ﬁlter is deﬁned as
𝐹(𝑟) =
⎧{
⎨{⎩
𝐼′𝑦(𝑟) − (𝐼 ′𝑧(𝑟) + 𝐼 ′𝑥(𝑟)) if 𝐼′𝑦(𝑟) ≥ 0,
0 otherwise.
(3.1)
𝐹(𝑟) can be interpreted as the likelihood of a speciﬁc voxel at location 𝑟 to belong
to an edge with 𝑦-gradient. The expression (𝐼′𝑧(𝑟) + 𝐼′𝑥(𝑟)), subtracted from 𝐼′𝑦(𝑟), can
be seen as a penalization term because high gradient values in 𝑧 and 𝑥 directions are
not expected in voxels that belong to the pectoral muscle surface. Figure 3.2(b) shows
an example.
The output of 𝐹(𝑟) is binarized by an adaptive threshold set to 𝑚𝑎𝑥(𝐹(𝑟))/4. We
identify the distinct structures of the binary volume by determining the connected
components69. The largest structure is identiﬁed as the pectoral boundary and the rest
is excluded. By doing so, smaller edges that do not belong to the pectoral boundary,
such as skin folds, are removed. Finally, a box-shaped Volume of Interested (VOI)
is placed in the center of the volume (see dotted box of Fig. 3.2(b)). The sternum
landmark is determined by computing the center of mass of the voxels of the largest
structure which are included in the VOI. In our experiments, the size of the VOI was
set to 34 x 156 x 14 mm to ensure that the sternum landmark was detected at any 𝑦
location of the center of the volume.
Figure 3.2: (a) MRI axial slice, with sternum indicated with a circle, and (b) the output obtained
applying the ﬁlter to detect the sternum point with a VOI (dotted box), as described in Eq. 3.1.
3.2.2 Image normalization
Bias ﬁeld correction minimizes the signal intensity variability of a given tissue within
a single acquisition. However, voxel values belonging to a speciﬁc structure vary from
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patient to patient due to diﬀerences on the build of each patient and diﬀerences on the
acquisition parameters. Ignoring the inter-patient variability can severely hamper the
ﬁnal segmentation of the diﬀerent tissues, especially in steps where image intensity is
used as a feature. Hence, signal intensity of all the scans needs to be standardized for
segmentation.
Among others, the sensitivity of the coil is one of the most important factors that
cause the diﬀerence between signal intensities of diﬀerent scans. Thus, if we deﬁne 𝑆𝑡
as the MR intensity corrected for coil sensitivity, we can write 𝐼(𝑟|𝑥𝑟 = 𝑡) = 𝛾𝑆𝑡, where
𝑥𝑟 is the label at location 𝑟, 𝑡 is the tissue type and 𝛾 is the factor that generates the
diﬀerence.
The factor 𝛾 can be canceled out by using the mean intensity value of a reference
tissue of the same scan:
̂𝐼(𝑟|𝑥𝑟 = 𝑡) = ̂𝐼𝑡 =
𝛾 𝑆𝑡
𝛾 𝑆𝑟𝑒𝑓
= 𝐼𝑡𝐼𝑟𝑒𝑓
, (3.2)
where ̂𝐼𝑡 is the normalized image intensity value for a tissue 𝑡 and 𝐼𝑟𝑒𝑓 is the image
intensity value of the reference tissue of the same scan. The fatty tissue was selected as
the reference as it is the most prominent tissue of the image and its intensity distribution
is easier to estimate than the distribution of other structures.
The estimation of the mean fatty tissue value, 𝐼𝑟𝑒𝑓 in Eq. 3.2, is performed in a VOI
containing all the voxels of the MR scan which are located anterior to the sternum.
Sternum detection is described in section 3.2.1. The dotted box of Fig. 3.3 illustrates
the VOI, which contains voxels belonging to fatty and glandular tissues, background
and, in some cases, voxels which belong to the pectoral muscles. The background is
excluded using Otsu thresholding70, leaving fatty, dense and pectoral muscle tissues.
The fatty mean intensity value is computed by means of the Expectation-Maximization
algorithm66. Pectoral muscle and ﬁbroglandular tissue have similar voxel values and
can be considered as a single class. The image intensity distributions of the two classes
(fatty and other tissues) are estimated by ﬁtting two Gaussian distributions.
Figure 3.3: Axial breast MR slice: the sternum is localized (ellipse) to deﬁne the VOI to estimate the
mean value of fatty tissue. Dotted box shows the VOI. The white highlighted tissue within the VOI
corresponds to the fatty tissue used as reference tissue in the image normalization process.
As an illustration, Fig. 3.4 shows the MR signal intensity distributions of the whole
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image of 5 diﬀerent cases before (a) and after (b) normalization. A better overlap can
be observed after normalization.
(a) (b)
Figure 3.4: Image normalization: intensity distribution of the whole image of 5 diﬀerent patients before
(a) and after (b) normalization.
3.2.3 Breast-body segmentation
In this stage, the breasts are identiﬁed as the region delimited by the breast-body sur-
face and the air-breast boundary. The breast-body surface is determined by segmenting
body structures using an atlas-based voxel classiﬁcation algorithm65. The atlas-based
approach uses a probabilistic atlas that provides the probability for each voxel to belong
to the body (pectoral muscle, heart, lungs and thorax) and the breast as a prior infor-
mation. A dedicated registration framework65, that focuses on the body area, is used
to build and map the probabilities. This registration is composed of two stages: trans-
lation transform, where the sternum is used as a landmark, and a non-rigid registration
based on a B-Splines transform in a multi-resolution scheme.
The air-breast boundary is deﬁned by a region growing algorithm applied slice by
slice. A morphological dilation ﬁlter with scale 5 x 5 mm is also performed on the
background segmentation to ensure that the skin between the background and the
breast is removed. The probabilistic atlas-based approach is not used to compute
the air-breast boundary because this approach was designed to capture anatomical
variations on body area.
Figure 3.5 shows the general scheme of the breast-body segmentation framework and
the results produced with its application. More details can be found in Gubern-Mérida
et al.65.
3.2.4 Breast density segmentation
In the previous breast-body segmentation step (see section 3.2.3), a general delineation
of the breast is obtained. This initial breast segmentation separates the breast from
the body, but it might still contain fatty tissue which is not part of the breast. In the
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Figure 3.5: Overview of the probabilistic atlas-based breast-body segmentation approach.
breast density segmentation step, the breast volume is ﬁrstly deﬁned for each breast
independently to remove the non-breast fatty tissue that could negatively inﬂuence the
estimation of breast density.
Figure 3.6 shows an illustration of the breast volume deﬁnition for the right breast.
Firstly, the breasts are separated by a sagittal plane (y-z) situated in the center of the
volume where the sternum was detected. Secondly, we deﬁne a coronal plane (x-y) at
2 cm posterior from the sternum landmark. Then, we exclude all the voxels which are
posterior to the plane. Finally, for each breast independently, the breast boundaries
are identiﬁed by detecting the superior and inferior points with maximum curvature of
the central sagittal slice of the breast. Axial planes (x-z) of Fig. 3.6 deﬁne the breast
boundaries of the right breast.
Figure 3.6: Breast volume deﬁnition for dense tissue segmentation: axial planes deﬁne the parts of the
breast with highest curvature. The coronal and sagittal planes are aligned to the sternum landmark.
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Once the breast volume for each breast is deﬁned, the dense tissue is segmented
using the Expectation-Maximization (EM) algorithm66 independently on each breast.
The EM is an iterative technique that maximizes the probability density function of a
mixture model. In this implementation the mixture model is composed by the image
intensity distributions of fatty and ﬁbroglandular tissues modeled as Gaussian distribu-
tions, taking advantage of the good contrast between breast tissues in MRI. The signal
intensity value that discriminates between fatty and ﬁbroglandular tissue is set to the
value where the likelihood ratio between the two estimated tissue models is one.
Large breasts often present folds, because the breast does not entirely ﬁt in the coil.
As can be seen in Fig. 3.7, these skin folds contain air and appear in the breast area
as horizontal structures in axial slices. Voxel values of skin folds have similar image
intensity values compared to dense tissue voxel values. This similarity causes skin fold
voxels to be segmented as a dense tissue by the EM algorithm applied on breast volume.
The erroneous segmentation of these structures can considerably bias the estimation of
breast density, especially in fatty breasts. For this reason, we included a ﬁnal step in
our algorithm to remove such structures from the dense tissue segmentation previously
generated by EM.
Figure 3.7: Skin fold examples.
The skin fold removal approach is applied to the whole volume that contains the
dense tissue segmentation of both breasts. It is based on the observation that skin
folds appear in axial slices as structures parallel to the chest wall connected to the
background. Firstly, a morphological dilation operation with the scale 4 x 4 x 4 mm
is applied to a binary volume composed by the union of dense tissue and background
segmentations. By doing so, background and skin fold voxels labeled as dense tissue
are connected to each other and are detected as the largest structure in a 3D connected
component analysis. Secondly, a ﬁrst derivative volume ̂𝐼′𝑦(𝑟) = 𝛿𝛿𝑦𝐺𝜎( ̂𝐼(𝑟)) is computed
at Gaussian scale 𝜎 = 5 mm to enhance the structures that run parallel to the 𝑥-axis.
The detection algorithm segments as skin fold the high 𝑦-gradient voxels with ̂𝐼′𝑦(𝑟) >
𝑚𝑎𝑥( ̂𝐼′𝑦(𝑟))/3 which belong to the glandular segmentation and to the background. If
skin folds are not present, only the background is found as the largest structure and no
dense tissue is removed.
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3.3 Experiments and results
The two main steps of the presented segmentation method were evaluated in detail using
a large annotated data set. Automatic separation of body and breast was evaluated on a
subset of 27 fully manually annotated MR volumes (see section 3.3.2). Fibroglandular
tissue segmentation was evaluated on a set of 50 cases with manual ﬁbroglandular
tissue segmentations of 4 diﬀerent experienced readers (see section 3.3.3). The complete
description of the used data set is presented in the following section.
3.3.1 Material
At the Radboud University Medical Center (Nijmegen, the Netherlands), breast MRI
is used for the screening of women with high familial or genetic risk. In this study we
used a random subset of 50 pre-contrast coronal T1-weighted MR breast volumes from
50 diﬀerent patients with no sign of malignancy within 2 years after the acquisition.
The age of the screened women ranged from 23 to 76 years (45.84 ± 11.97 of average).
The cases were collected from 2003 to 2009. Breast MRI examinations were performed
on either a 1.5 or 3 Tesla Siemens scanner (Magnetom Vision, Magnetom Avanto and
Magnetom Trio), with a dedicated breast coil (CP Breast Array, Siemens, Erlangen).
Clinical imaging parameters varied; matrix size: 256 x 128 or 256 x 96; slice thickness:
1.3 mm; slice spacing: 0.625 - 1.25 mm; ﬂip angle: 8 ∘, 20 ∘ or 25 ∘; repetition time:
7.5 - 9.8 ms; echo time: 1.7 - 4.76 ms. Patients were scanned in prone position. Note
that, although the MR images were acquired in coronal orientation, all the annotations
were performed using axial orientation and the illustrated images in this paper are axial
slices.
In order to evaluate the automatic breast segmentation algorithm and construct the
atlas, 27 cases were manually segmented in 7 structures by a single experienced observer.
The classes are background, fatty tissue, glandular tissue, pectoral muscles, lung area
and the heart. The seventh class is the “other” class and refers to the previous non-
labeled voxels of the thorax. Annotations were done every 5-10 axial slices on average,
and linear interpolation was applied to obtain the complete labeling. When needed, and
especially for the heart, lungs and pectoral muscles, accurate manual delineation was
performed within a smaller slice interval. For the manual segmentation of background
and the breast, thresholding was applied on regions of interest provided by the reader.
The manual segmentation of the breast dense tissue is explained further in this section.
Fig. 3.8 shows an example of an MRI slice on an axial view and the manual delineation
of the mentioned classes. One should note that obtaining manual annotations of the
6 diﬀerent classes for the breast segmentation is a tedious and time consuming task.
Each volume takes approximately 45 minutes in a dedicated breast MRI annotation
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environment71. This is the reason why a subset of 27 women out of the 50 cases is used
for evaluating breast segmentation.
Figure 3.8: Breast MRI scan on an axial slice with manual annotations of the diﬀerent structures
Independently, ﬁbroglandular manual segmentations from diﬀerent viewers were also
collected for the complete data set. Firstly, an experienced observer annotated a VOI
in each of the 100 breasts in the 50 cases, by coarsely encapsulating all the dense tissue
while avoiding inclusion of skin folds and fatty tissue areas where signal intensity is
dimmed due to the bias ﬁeld. This VOI is called dense tissue mask in the paper.
To delineate the dense tissue masks, the experienced observer analyzed and annotated
axial slices of each MR volume using a freehand annotation tool. Secondly, 4 diﬀerent
readers segmented ﬁbroglandular tissue. Each reader selected a single threshold on
the dense tissue mask of each breast to discriminate between ﬁbroglandular and fatty
tissue. The thresholds were applied on bias ﬁeld corrected volumes. As a result, 4
manual ﬁbroglandular segmentations for right and left breasts were obtained for each
case.
3.3.2 Breast-body segmentation
For each of the 27 fully manually segmented patients, the probabilistic atlas was built
with the remaining subjects (𝑁 = 26) in a leave-one-out fashion. These 26 patients and
their segmentations were mapped into the same reference space and the probabilities
were computed65. The same reference space was used for all the experiments. It was
represented by a patient with normal appearance to minimize the diﬀerences in the
registration process. This patient was not included in the evaluation set.
These 27 cases were automatically segmented and compared to their complete man-
ual segmentations. For the evaluation of breast and body delineations we determined
breast segmentation performance. Dice Similarity Coeﬃcient (DSC)72, total overlap,
and False Negative Fraction (FNF) and False Positive Fraction (FPF) errors are em-
ployed as done in42, where breast segmentation is also evaluated. DSC is widely used
in the literature to evaluate segmentation agreement and is also referred to as mean
overlap. The total overlap is computed as the sensitivity. The FNF error gives the
fraction of the breast reference segmentation that is not segmented as the breast by the
automatic segmentation. Similarly, the FPF error gives the fraction of the automatic
3.3 Experiments and results 33
segmentation of the breast that is not segmented as the breast by the reference segmen-
tation. More details about these measures can be found in Klein et al.73. Furthermore,
since similarity between voxel values of pectoral muscle and ﬁbroglandular tissue is the
reason why breast-body separation is not trivial, we provide a complementary evalua-
tion: the fraction of ﬁbroglandular tissue voxels of the reference segmentation labeled as
body in the automatic segmentation of the breast. We refer to this evaluation measure
as Dense Tissue Error (DTE). To compute this metric, the ﬁbroglandular tissue refer-
ence segmentation was built by combining the 4 manual dense tissue segmentations of
each observer using STAPLE74. The STAPLE algorithm fuses a collection of manual
segmentations maximizing the accuracy assessment of each expert. The DTE metric
was not previously used in the literature, but we consider it relevant to quantify the
segmentation error in combination with other overlap measures.
Figure 3.9 shows a box plot with the distribution of overlap and error metrics used
for breast segmentation evaluation. The average DSC value was 0.94±0.03 (mean± sd),
the average total overlap was 0.96±0.02 (mean ± sd), the average FNF was 0.04±0.02
(mean ± sd), the average FPF was 0.07 ± 0.06 (mean ± sd) and the average DTE was
0.02 ± 0.03 (mean ± sd). The DTE was useful to observe the inﬂuence of pectoral
muscle in the breast-body surface segmentation. The majority of the ﬁbroglandular
voxels automatically misclassiﬁed as body (93.75%) belonged to pectoral muscle, which
is included in the body. Accurate delineations are achieved as is illustrated in Fig. 3.10.
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Figure 3.9: Breast segmentation performance: (a) distribution of overlap DSC and total overlap metrics
and (b) distribution of error overlap False Negative Fraction (FNF), False Positive Fraction (FPF) and
Dense Tissue Error (DTE).
The sternum localization and its inﬂuence on the breast segmentation stage was also
evaluated. Each case was annotated with a manually centered sternum point. Manual
landmarks of the outer edge of the sternum were compared to the sternum localizations
determined automatically. An average error of 1.51±1.34 mm (1.16±1.03 voxels) was
obtained, which shows the validity of our sternum detection approach. To evaluate the
impact on the ﬁnal segmentation, the automatic breast-body segmentation approach
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Figure 3.10: Intermediate slices from 3 diﬀerent cases and the breast contour obtained from the
segmentations.
was also tested without incorporating the sternum landmark detection. When the
sternum point was incorporated, an improvement was observed in the performance
of pectoral muscle segmentation. A DSC mean value of 0.75 ± 0.09 (mean ± sd)
was obtained for pectoral muscle segmentation. When the sternum point was not
incorporated, the DSC value decreased to 0.71 ± 0.12 (mean ± sd). In fatty cases,
where the registration is more complicated because of the large amount of fatty tissue
between the body and the background (ie. case (b) of Fig. 3.10), the localization of the
sternum appears to be essential as can be seen in the example in Fig. 3.11.
(a) (b)
Figure 3.11: Breast segmentation of the case 7 with (a) and without (b) the use of sternum landmark
in registration.
3.3.3 Breast density segmentation
In order to evaluate the breast density segmentation, several experiments were per-
formed. Firstly, inter-observer variability was studied analyzing the 4 manual segmen-
tations of the 50 cases (100 breasts). Secondly, to show the validity of the EM algorithm
for ﬁbroglandular tissue segmentation, we also segmented dense tissue of the 50 cases
using the EM algorithm on the manually segmented dense tissue masks employed in
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manual thresholding. Finally, breast density segmentations from the complete data set
were obtained using the presented fully automatic approach, which includes all steps:
automatic breast segmentation and density segmentation using EM.
STAPLE74 was used to fuse manual segmentations and build multiple ﬁbroglandular
tissue reference segmentations. To evaluate inter-observer variability, a leave-one-out
strategy was followed and each manual segmentation was compared to a reference seg-
mentation created by fusing manual delineations of the 3 remaining readers. In total,
four ﬁbroglandular tissue reference segmentations were created for each case. To evalu-
ate our approach, automatic segmentations were compared to each of the four reference
segmentations and the average was taken. DSC, total overlap, FNF and FPF were
chosen to quantify the performance of breast density segmentation. Two-sided paired
Wilcoxon test at 95% conﬁdence level was used to determine statistical signiﬁcance.
The results presented in Table 3.1 and in Fig.3.12 indicate that our EM algorithm
is comparable to manual thresholding when applied on a manually deﬁned dense tis-
sue area. In terms of DSC, which is the metric used by Wu et al.63,64 to evaluate
the performance of their fully automatic ﬁbroglandular tissue segmentation algorithms,
it outperforms segmentations of viewer 3 (p-values < 0.025) and diﬀerences are not
signiﬁcant when compared to viewer 1, 2 and 4 (p-values of 0.20 and 0.54 and 0.54
respectively). When the fully automatic method is applied, the performance decreases
to 0.80. However, automatic segmentations have similar performance compared to that
obtained by viewer 3 (p-value of 0.65). Figure 3.13 shows reference and automated
ﬁbroglandular segmentations on two axial slices from the best and worst automatic
segmented cases. In the worst case example, the pectoral muscle is segmented as ﬁ-
broglandular tissue due to registration errors and the skin fold was not totally removed.
Although the skin fold is still present in this example, overall, the skin fold removal
step appeared to be important: The results obtained by the proposed fully automatic
approach, which includes skin fold removal, signiﬁcantly outperforms the ﬁbroglandular
tissue segmentations obtained without detecting such structures (average DSC values
of 0.80 ± 0.12 (mean ± sd) and 0.75 ± 0.14 (mean ± sd) respectively, with p-value <
0.025).
Finally, the volume of dense tissue was computed using the ﬁbroglandular tissue seg-
mentations of the automated approach and the reference segmentations. For each case
and segmentation, dense volume estimation of the right and left breast was compared.
Figure 3.14 illustrates the correlation (0.93 and 0.91) between right and left breast den-
sities for (a) fully automatic and (b) reference segmentations. Numbers indicate the
case identiﬁer. Assuming that the right and left breasts tend to have the same density,
the similarity of volumetric estimates obtained for left and right breasts demonstrates
the consistency of the method we developed. Similarly, correlation between breast den-
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Table 3.1: Average DSC, average total overlap, average FNF and average FPF (mean ± sd) obtained
from manual segmentations of the 4 diﬀerent viewers, from Expectation-Maximization algorithm ap-
plied on manually deﬁned dense tissue area (EM mask) and, from EM algorithm applied on automatic
deﬁned breast volume (Automatic).
DSC T. Overlap FNF FPF
V1 0.84 ± 0.11 0.77 ± 0.17 0.23 ± 0.17 0.04 ± 0.07
V2 0.88 ± 0.08 0.93 ± 0.11 0.07 ± 0.11 0.15 ± 0.12
V3 0.80 ± 0.15 0.95 ± 0.08 0.05 ± 0.08 0.28 ± 0.21
V4 0.85 ± 0.12 0.77 ± 0.17 0.23 ± 0.17 0.02 ± 0.03
EM mask 0.86 ± 0.10 0.89 ± 0.11 0.11 ± 0.11 0.14 ± 0.15
Automatic 0.80 ± 0.13 0.85 ± 0.11 0.15 ± 0.11 0.22 ± 0.18
sity measures computed from automatic and reference segmentations was substantial,
reaching breast-based and case-based correlation ratios of 0.89 and 0.92, respectively
(see Fig.14(c)).
3.4 Discussion and conclusions
The segmentation framework we developed to automatically compute breast density by
segmenting breast and ﬁbroglandular tissue in breast MRI shows good performance for
both automatic segmentation tasks. The presented method is a combination of image
processing techniques. Intra- and inter-patient signal intensity variability is initially
corrected. Secondly the breast is segmented by automatically detecting body-breast
and air-breast surfaces using an atlas-based approach. Subsequently, the ﬁbroglandular
tissue is segmented by EM algorithm and skin-fold removal.
Diﬀerent stages of our method have been validated. Automatic segmentations of
breast and ﬁbroglandular tissue were compared to manual segmentations. Overall,
qualitative and quantitative results show that the obtained segmentations are of high
quality in most cases. With respect to the ﬁbroglandular tissue segmentation, good cor-
relation between breast density estimates obtained in the right and left breast indicates
consistency and robustness of our approach.
We observed that the inclusion of the sternum landmark in the registration frame-
work improves the segmentation of the breast-body surface. This is important because
erroneous inclusion of pectoral muscle tissue in the breast is a major source of errors
in methods aimed at automated segmentation of ﬁbroglandular tissue. The sternum
landmark was detected automatically and this detection was reliable since results we
obtained were similar to manual annotations.
Compared to previous work found in the literature, for breast segmentation, our
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Figure 3.12: Fibroglandular tissue segmentation: distribution of DSC and total overlap measures
computed from manual segmentations of the 4 diﬀerent viewers (V#), from Expectation-Maximization
algorithm applied on manually deﬁned dense tissue area (EM mask) and, from EM algorithm applied
on automatic deﬁned breast volume (Automatic).
performance metric values are higher than the reported by Gallego-Ortiz et al.42. With
our approach we achieved an average DSC value of 0.94 ± 0.04 (mean ± sd) and an
average total overlap of 0.96±0.02 (mean ± sd). Their breast segmentation framework
obtained an average DSC value of 0.88±0.05 (mean ± sd) and an average total overlap
of 0.89 ± 0.05 (mean ± sd). However, Gallego-Ortiz et al. validated their approach on
409 MRI cases, which is larger than the 50 used in our work, and reported computational
time of less than a minute per volume. Our approach takes approximately 8 minutes
computed on a 4 Intel(R) Core(TM) i5-2400 CPU 3.10GHz processors system with
12 GB RAM. Most of this time is spent by our algorithm to register and map the
probabilistic atlas to the target image (≈ 6 min.). However, one should note that the
current implementation of this step is single-threaded. Therefore, the computational
time can be substantially decreased by multithreading the task.
For the automatic ﬁbroglandular tissue segmentation, we obtained an average DSC
value of 0.80 ± 0.13 (mean ± sd). The DSC value is higher than the values of 0.73
and 0.67 reported by Wu et al.63,64. These authors also reported a value of 0.93 for
case-based ﬁbroglandular tissue volume correlation between automatic and manual seg-
mentation64. In our study, we obtained a case-based ﬁbroglandular tissue volume cor-
relation of 0.92.
It should be noted that not too much importance should be given to these com-
parisons, since the segmentation results were determined on diﬀerent data sets. The
composition of these sets may have a strong inﬂuence on the overall results, especially
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Figure 3.13: Fibroglandular tissue segmentation results: comparison of reference and automated seg-
mentation of two axial slices from the best and worst automatic segmented cases.
0 50 100 150 200 250
0
5
0
1
0
0
1
5
0
2
0
0
2
5
0
Right breast density estimation (cm³)
L
e
ft
 b
re
a
s
t 
d
e
n
s
it
y
 e
s
ti
m
a
ti
o
n
 (
c
m
³)
Breast density estimation automatic
 (R=0.93 (0.88−0.96))
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
3
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
0 50 100 150 200 250
0
5
0
1
0
0
1
5
0
2
0
0
2
5
0
Right breast density estimation (cm³)
L
e
ft
 b
re
a
s
t 
d
e
n
s
it
y
 e
s
ti
m
a
ti
o
n
 (
c
m
³)
Breast density estimation reference
 (R=0.91 (0.85−0.95))
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
0 50 100 150 200 250
0
5
0
1
0
0
1
5
0
2
0
0
2
5
0
Automatic breast density estimation (cm³)
R
e
fe
re
n
c
e
 b
re
a
s
t 
d
e
n
s
it
y
 e
s
ti
m
a
ti
o
n
 (
c
m
³)
Breast density estimation
 (R=0.92 (0.87−0.96))
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
9
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
(a) (b) (c)
Figure 3.14: Correlation between right and left breast density estimations using (a) fully automatic
and (b) reference segmentations and (c) case-based correlation between breast density estimations from
automatic and reference segmentations. Numbers refer to the identiﬁer of each case.
when sets are small. Data sets represent diﬀerent populations and the way manual an-
notations are made may also cause diﬀerences. For instance, we observed that the area
covered by the manual breast segmentations used in our experiments is larger than the
area covered by the manual segmentations used by Gallego-Ortiz el al.42. These diﬀer-
ences are caused by the diﬃculty of determining the anatomical extent of the breast,
in particular the lateral zone where the breast is connected to the chest wall.
Using the presented method, we found that most of the remaining errors in au-
tomated ﬁbroglandular tissue segmentation are due to an inaccurate deﬁnition of the
breast-body surface. In the experiments, in three of the cases the breast segmentation
algorithm classiﬁed more than 6 % of dense tissue voxels as body (DTE > 0.06), which
indicates that a substantial amount of body voxels were erroneously labeled as dense
tissue. This error was observed in cases where the registration was not able to compen-
sate for diﬀerences between the target and the atlas. Hence, probability distributions
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of body and breast were not correctly mapped leading to errors in the ﬁnal segmenta-
tion. To improve results in such cases, the use of a multi-probabilistic atlas approach
can be considered, in which diﬀerent probabilistic atlases would be created for diﬀerent
populations of breast MRI cases, grouped based on shape and/or patient age. For a
given case, the most similar atlas to the target image would be chosen to proceed with
the segmentation. A disadvantage of this approach, however, is that it may lead to a
strong increase in computational load.
The use of a diﬀerent threshold to segment ﬁbroglandular tissue for each breast
appeared to be important. During the development of our algorithm, we found that
the use of a single threshold for both breasts produced a strong asymmetry between
left and right breast density estimations. This asymmetry was caused by diﬀerences
in signal intensities between left and right breasts. We considerably reduced it and
improved overall performance of the presented method by applying the N3 bias ﬁeld
correction method and by segmenting each breast independently. We also observed that
the bias ﬁeld is not completely removed after correction in cases with large breasts. The
bias ﬁeld causes lower signal intensity values in fatty tissue areas of the base breast and
this fatty tissue is incorrectly segmented as ﬁbroglandular tissue. To overcome this
limitation the eﬀect of applying other bias ﬁeld correction algorithms75 will be studied
in the future.
The method in our study has been developed and evaluated using data collected
in only one clinical center. Therefore, robustness against diﬀerences in population and
image acquisition systems could not be investigated. However, we are conﬁdent that,
with minor adjustments, the proposed segmentation framework for breast MRI is suit-
able for application to data sets obtained in diﬀerent institutions and under diﬀerent
conditions, since our dataset contained images obtained on diﬀerent scanners with dif-
ferent clinical imaging protocols and our method only uses a few parameters. These
parameters are related to sternum detection and skin-fold removal. Experimentally we
found that the performance of our method did not critically depend on the values of
these parameters.
The probabilistic atlas we used captures anatomical information. Since it is learned
from a selected population, care must be taken that the atlas is representative for
the population the method is applied to. The atlas is not dependent on the image
acquisition protocols, but obviously it needs to be rotated and scaled to the correct
coordinate frame. It is remarked that the use of diﬀerent breast coils may lead to some
variations that are not represented in an atlas constructed from a single acquisition
system. However, since this predominantly aﬀects the atlas values of breast tissue, this
does not aﬀect our method, in which the atlas is only used for the breast-body surface
segmentation.
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To summarize, in this paper we have presented a new fully automatic approach to
measure the volume of dense tissue in breast MRI. The previously published segmen-
tation methods either required manual intervention, were evaluated on small data sets,
or were focused only on breast-body separation. Evaluation on a substantial data set
of ﬁfty cases with multiple manual annotations has shown that our approach yields
fairly accurate automatic segmentations. Therefore, we believe that our segmentation
method can serve as a reliable tool in breast density studies, such as investigating
the correlation between breast density measurements obtained from MRI and mammo-
grams. Although there is no consensus on the role of breast density as an individual
risk factor for breast cancer, population based studies have shown that there is a strong
relation between breast density and breast cancer occurrence. The presented segmen-
tation framework, as well as its diﬀerent stages independently, can be also applied in
other clinical applications for breast cancer. For instance, ﬁbroglandular tissue mor-
phology and distribution patterns can be analyzed to investigate their relationship with
risk of developing cancer, and automated segmentations may be used in computer aided
diagnosis programs.
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Abstract
Objectives: To objectively evaluate automatic volumetric breast density assessment
in Full-Field Digital Mammograms (FFDM) using measurements obtained from breast
Magnetic Resonance Imaging (MRI).
Material and methods: A commercially available method for volumetric breast den-
sity estimation on FFDM is evaluated by comparing volume estimates obtained from
186 FFDM exams including mediolateral oblique (MLO) and cranial-caudal (CC) views
to objective reference standard measurements obtained from MRI.
Results: Volumetric measurements obtained from FFDM show high correlation with
MRI data. Pearson’s correlation coeﬃcients of 0.93, 0.97 and 0.85 were obtained for
volumetric breast density, breast volume and ﬁbroglandular tissue volume, respectively.
Conclusions: Accurate volumetric breast density assessment is feasible in Full-Field
Digital Mammograms and has potential to be used in objective breast cancer risk models
and personalized screening.
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4.1 Introduction
Breast density has been identiﬁed as an important risk factor for developing breast
cancer. Studies have reported that the risk of getting breast cancer in women with high
breast density is four to six times as large as in women with low breast density10,58,76.
Additionally, sensitivity of mammography screening is severely impaired in women with
high density, since the presence of heterogeneous or extreme dense tissue patterns may
obscure suspicious lesions. For this reason, the risk of missing cancers in screening
programs increases with density5,7,77. Personalization of screening protocols, involv-
ing adjunct imaging modalities for women who are currently not adequately screened,
has been suggested to circumvent this problem. Such protocols should include risk
assessment based on models including family history and breast density biomarkers11.
To develop such models, it is important to objectively measure breast density. Most
studies to date have been performed using subjective visual measurements based on
the 4-class Breast Imaging Reporting and Data Systems (BI-RADS)78, which is used in
current clinical practice, or on a visual thresholding technique using dedicated software,
such as Cumulus79. Both are essentially 2D measurements that determine the area of
dense tissue projected in mammograms. Fully automatic methods for area based breast
density measurements have been proposed to take subjectivity away80–83. However, area
based measurements do not take the thickness of dense tissue into account. This is a
limitation since it is biologically more plausible that breast cancer risk is related to the
volume of dense tissue in the breast rather than to its projection58,84,85.
To overcome this limitation, methods for volumetric breast density estimation from
mammograms have been proposed45,46,86–89. These methods are based on a physics
based model of the X-ray image acquisition process and assume that the breast tissue
consists of two types of tissue: fat and parenchyma. By knowing the X-ray attenua-
tion of these tissues, tissue composition at a given pixel can be computed. Initially,
researchers have struggled to successfully apply this approach to digitized ﬁlm mammo-
grams. However, with the introduction of Full-Field Digital Mammograms (FFDM),
the development of robust methods and commercial products became possible. Those
can be applied to raw (unprocessed) FFDM data, which is made available by all modal-
ity manufacturers. Unfortunately, though, raw data is often not archived in clinical
practice.
The performance of volumetric breast density estimation methods has been eval-
uated in several studies. To determine robustness and consistency, comparisons have
been made of breast density estimates in the left and right breasts, and in mediolateral
oblique (MLO) and cranial-caudal (CC) exposures of the same breast45,86. One would
expect to ﬁnd similar values in CC and MLO views and, in regular cases without abnor-
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malities, breast density in the left and right breast should be highly correlated. Other
studies compared volumetric estimates to BI-RADS density scoring90,91. These previ-
ously mentioned validation strategies may not reveal systematic errors, while subjective
BI-RADS scorings are coarse and inaccurate by nature and are only useful to determine
large errors of the automated methods. Comparison of breast density estimates from
FFDM to reference standard measurements obtained from three-dimensional imaging
modalities, such as Magnetic Resonance Imaging (MRI) and Computed Tomography
(CT), is arguably the most objective and complete validation method45,46,92,93. The
volume of dense breast tissue can accurately be derived from MR and CT images, as
these are 3D acquisitions and no projection is involved. However, quantiﬁcation of the
volume of dense breast tissue is a time consuming task when done by means of manual
segmentations because it requires segmentation of 3-dimensional data. For this reason
we use computer algorithms to obtain breast density measurements.
In this paper, we evaluate a method for measuring volumetric breast tissue estimates
from digital mammograms45,46. We speciﬁcally studied the performance of the method
for determination of ﬁbroglandular tissue volume, breast volume, and volumetric breast
density by comparing its results to volume estimates that were obtained from breast
MRI data.
4.2 Materials and methods
4.2.1 Dataset
Ethics Statement: According to the Dutch Medical Research Involving Human Subjects
Acts (WMO), retrospective studies using only patient records do not require a formal
medical ethics review and informed consent is not needed. The need for signed informed
consent was waived by the Independent Review Board (IRB). This was conﬁrmed with
the local medical ethical committee and can be read at www.ccmo-online.nl. The
presented study complies with the Dutch Data Protection Authority requirements on
the use of patient data.
In the Radboud University Medical Center (Nijmegen, the Netherlands), breast
MRI and mammography are used for screening of women with high familial or genetic
risk. We included studies for which breast MRI data and FFDM were available with
time interval between these exams of less than two months. We obtained 250 MRI vol-
umes and 928 MLO and CC images from FFDM exams from 250 studies (132 diﬀerent
women). Mean time between MRI and FFDM acquisitions was six days. CC views
were not available in some cases. All exams were performed between December 2000
and December 2011. The age of the screened women ranged from 24 to 77 years, and
was 46.5 ± 11.10 years on average.
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The digital mammograms used in the study were acquired on a GE Senographe
2000D or on a GE Senographe DS using standard clinical settings, including the use
of an anti-scatter grid. Breast MRI examinations were performed on 1.5 or 3 Tesla
scanners (Magnetom Vision, Magnetom Avanto and Magnetom Trio, Siemens) with a
dedicated breast coil (CP Breast Array, Siemens). In this study we used pre-contrast
T1-weighted MR volumes.
4.2.2 Breast density quantiﬁcation
In this study, volumetric breast density, breast volume and ﬁbroglandular volume es-
timates were obtained from FFDM and MRI data. Volumetric breast density refers to
the percentage of breast density, computed by dividing the ﬁbroglandular tissue volume
by breast volume.
Volumetric estimates from 250 FFDM studies were obtained using Volpara 1.4.3
(Mātakina, Wellington, New Zealand), which is FDA-approved fully automated software
to estimate volumetric breast density. The Volpara method is an extension of the
algorithm presented by van Engeland et al.45. In particular, it incorporates a more
detailed physics model including scatter components as described by Highnam et al.87,
and it uses a more advanced method to determine a reference region of fatty tissue. This
reference region is used for calibration, and allows computation of ﬁbroglandular tissue
thickness at every pixel in the image. Breast volume is determined using a geometric
model in which the periphery of the compressed breast is modeled by semi-circular cross
sections, using the breast thickness measurement provided by the acquisition system in
the image header.
Volumetric measurements from MRI were obtained using a multi-probabilistic atlas-
based segmentation method based on the work of Gubern-Mérida et al.50,65. In short,
the breast MRI segmentation method initially corrects the bias ﬁeld and normalizes
signal intensities among patients. Secondly, probabilistic atlases, which capture the
anatomic variation of the pectoral muscle and chest wall, are used to segment the
breast. A probabilistic atlas is a volume that contains the complete spatial distribution
of probabilities of voxels to belong to one or more organs65. Finally, the ﬁbroglandular
tissue is segmented in each breast independently using automatic thresholding. In
this work, this method was used to automatically segment breast and ﬁbroglandular
tissue in the 250 MRI studies. A radiologist with expertise in breast imaging carefully
reviewed all slices of the segmentations and approved 186 (74.4%) MRI studies with
segmentations to be suitable for the use as a reference standard for validation of FFDM
density measurements. The other 64 (25.6%) studies were excluded from the study.
The ﬁeld of view of 5 of the excluded cases did not entirely cover the breast. In the
rest of the excluded cases we observed that the main reason for the MRI segmentation
46 Validation of volumetric breast density estimations from FFDM using MRI
failure was the presence of artifacts or bias ﬁeld remaining after correction. These signal
intensity distortions negatively aﬀected the segmentation process.
4.2.3 Validation
The validation process is represented in Fig. 4.1. The Volpara method was validated on
186 FFDM exams including 680 mammographic views. The Pearson’s correlation co-
eﬃcients between volumetric measures obtained from FFDM and volumetric measures
obtained from MRI were calculated per breast and per study. The volumetric estima-
tions per breast from FFDM were averaged over available measures of CC and MLO
views for each breast independently. Measures per study were computed by averaging
right and left breast volumetric estimates. Because of the log-normal distribution of the
data, correlation coeﬃcients were computed after converting the measurements using
the natural logarithmic transform91.
Figure 4.1: Schematic overview of the validation process.
Scatter plots are used to visualize the comparison between breast volumetric estima-
tions. Volpara Density Grade (VDG) thresholds are also shown for volumetric breast
density estimates obtained from FFDM. The VDG is a grading system that maps the
percent density output of Volpara into four categories similar to the BI-RADS density
score. The ranges of the percentage of dense tissue for VDG 1, 2, 3 and 4 are 0 − 4.5%,
4.5 − 7.5%, 7.5 − 15.5% and 15.5% and up, respectively94.
BI-RADS density scoring (1 to 4) was also performed on the 250 FFDM stud-
ies. Each study was classiﬁed as (1) fatty, (2) scattered dense, (3) heterogeneously
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dense or (4) extreme dense by a breast radiologist. Volumetric breast density mea-
surements obtained from FFDMs and MRI, computed per study, were compared to its
BI-RADS category provided by the radiologist and the Spearman Ranked correlations
were computed for each modality. Finally, to quantify the concordance between VDG
and BI-RADS density score, the weighted kappa with quadratic weights coeﬃcient was
measured.
4.3 Results
Table 4.1 summarizes the results obtained in this validation study. Figure 4.2 shows the
relation between percentage of volumetric breast density from mammograms and MRI
data per breast (a) and per study (b). Correlations per breast and per study are 0.91 and
0.93, respectively. Figure 4.3 shows the relation between breast volume estimates from
mammograms and MRI data. Per breast (a) and per study (b) correlations are both
0.97. Additionally, Fig. 4.4 shows the relation between ﬁbroglandular tissue volume
estimates from mammograms and MRI data. Correlation per breast (a) is 0.84 and
correlation per study (b) is 0.85.
Table 4.1: Summary of the dataset and the results obtained in this study. IQR=inter-quartile range,
*=Pearson correlation coeﬃcient, +=Spearman Ranked correlation coeﬃcient, -=weighted kappa with
quadratic weights coeﬃcient.
Number of studies 186
Number of mammographic views 680
Number of breasts 353
FFDM (Median (IQR)) MRI (Median (IQR))
Volumetric breast density (%) 11.90 (12.86) 13.55 (17.15)
Breast volume (cm3) 551.95 (405.32) 643.16 (439.56)
Fibroglandular tissue volume (cm3) 60.45 (50.36) 76.27 (72.20)
Per breast Per study
Volumetric breast density correlation
- FFDM - MRI 0.91* 0.93*
- FFDM - BI-RADS - 0.78+
- MRI - BI-RADS - 0.77+
- VDG - BI-RADS - 0.40-
Breast volume correlation
- FFDM - MRI 0.97* 0.97*
Fibroglandular tissue volume correlation
- FFDM - MRI 0.84* 0.85*
Overall, high correlation between FFDM and MRI measurements is observed. How-
ever, results indicate that Volpara tends to underestimate breast density in dense breasts
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Figure 4.2: Comparison of percentage of breast density from MRI and FFDMs (a) per breast (n =
353) and (b) per study (n = 186). Each point is labeled with the BI-RADS score. VDG 1, 2, 3 and 4
refer to Volpara Density Grade breast density percentage ranges.
compared to MRI. Correlation drops for volumetric breast density measurements clas-
siﬁed within the VDG 4 range.
Furthermore, Fig. 4.5 shows the association between volumetric breast density esti-
mates and BI-RADS category. The estimates are obtained from FFDMs on Fig. 4.5(a),
and obtained from MRI on Fig. 4.5(b). Spearman Rank correlation coeﬃcients are 0.79
and 0.78 for FFDM and MRI, respectively. The reported correlations are not statis-
tically signiﬁcantly diﬀerent (p-value = 0.71, two-tailed z-test). Following the trend
observed before, volumetric breast density estimates are larger when obtained from
MRI than when computed on FFDMs. The median estimates obtained with Volpara
range from 5.66%, in the lowest BI-RADS category, to 26.69%, in the top category.
Median estimates obtained from MRI data range from 3.80% to 52.00%. Figure 4.6
shows the number of studies scored with BI-RADS categories 1, 2, 3 and 4 for (a) the
initial dataset and for (b) the dataset after excluding studies with poor MR segmen-
tations. Finally, Table 4.2 shows the confusion matrix for the VDG using the Volpara
method versus BI-RADS density score given by the breast radiologist. The weighted
kappa with quadratic weights statistic was 0.40.
4.4 Discussion
In this study we have presented a validation of Volpara 1.4.3 (Mātakina, Wellington,
New Zealand), which is a commercially available method for assessing volumetric breast
density on FFDM. Volpara has been evaluated on 186 studies including 680 mammo-
graphic views of 353 breasts in total. Volumetric estimates obtained from FFDM have
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Figure 4.3: Comparison of breast volume obtained from MRI and FFDMs per (a) breast (n = 353)
and (b) per study (n = 186).
Figure 4.4: Comparison of ﬁbroglandular tissue volume obtained from MRI and FFDMs (a) per breast
(n = 353) and (b) per study (n = 186).
been compared to objective reference standard measures computed from MRI. Volumet-
ric breast density and breast tissue volume values obtained with Volpara present high
correlation when compared to MRI measurements. To date, this is the largest valida-
tion study that compares volumetric breast density estimates from FFDM to reference
standard measurements obtained from MRI, a 3D imaging modality.
In previous work, Wang et al.93 used a dataset of 123 patients and also compared
volumetric measurements obtained from FFDM to estimates obtained from MRI. Cor-
relations for breast volume, ﬁbroglandular tissue volume and volumetric breast density
were 0.94, 0.62 and 0.71, respectively. We found higher correlation values than the ones
reported in their work (R=0.97, R=0.85 and R=0.93 for breast volume, ﬁbroglandular
tissue volume and volumetric breast density, respectively). Van Engeland et al.45 also
compared density estimates from FFDM to estimates from MRI in a small study includ-
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Figure 4.5: Association between volumetric breast density estimates per study and BI-RADS category.
Figure 4.6: Frequency of studies scored with BI-RADS categories 1, 2, 3 and 4 for (a) the complete
dataset (n = 250) and (b) for the cases of the dataset with reference standard estimates (n = 186).
ing 22 patients, but only reported correlation between ﬁbroglandular tissue volume from
mammograms and from MRI data. The correlation was 0.97. In our study we found
a lower correlation between ﬁbroglandular tissue volume from FFDM and from MRI
(R=0.84). In previous studies, Volpara was also compared to semi-automatic area-based
density measurements. High correlation between the volumetric breast density obtained
with Volpara and area-based percentage density using Cumulus was found (R=0.85)91.
Care should be taken when comparing the correlation coeﬃcients obtained in this work
to the values reported in similar studies; these similar studies were performed on diﬀer-
ent datasets. In our study, the dataset was mostly composed of pre-menopausal women
participating in a high-risk screening program. In this dataset, a diﬀerent distribution
of breast density may be expected when compared to breast density distributions of
other datasets, since there are many factors that inﬂuence breast density (such as age
and use of hormone replacement therapy). On the other hand, we may assume that the
appearance of ﬁbroglandular tissue itself in our study group is similar to that in other
studies, since there is no evidence that breast density patterns in women in a high risk
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Table 4.2: Volpara Density Grade (VDG) versus BI-RADS density score from a breast radiologist.
BI-RADS
1 2 3 4
1 2 0 0 0 2
Volpara (VDG) 2 10 19 0 0 29
3 2 70 5 0 77
4 0 16 55 7 78
14 105 60 7 186
population diﬀer from those in the general population.
Compared to volumetric measurements obtained from MRI, results show that Vol-
para tends to underestimate breast density in very dense breasts. This eﬀect has been
also observed in other methods for volumetric breast density estimation45,95. Like Vol-
para, these methods are also based on a physics-based image model and, to predict
ﬁbroglandular tissue thickness, use a set of pixels of the breast that belong to fatty
tissue as an internal reference. The selection of the internal reference is more complex
in dense breasts than in fatty breasts, which aﬀects the calibration of fatty tissue at-
tenuation and leads to breast density underestimation. However, the breast density
underestimation in dense cases does not seem to aﬀect the ﬁnal VDG categorization.
We observed that the cases with the largest negative diﬀerence between estimates from
FFDM and MRI obtained a volumetric breast density estimate from FFDM greater
than 15% and were classiﬁed as VDG 4.
Compared to BI-RADS density scores given by a breast radiologist, a clear associa-
tion is observed, but low agreement between VDG scores and BI-RADS density scores
was found (weighted kappa with quadratic weights coeﬃcient = 0.40). In general, VDG
scores tend to be higher than the BI-RADS density scores. For instance, 70 studies that
were scored with BI-RADS 2 obtained a VDG score of 3. The same trend was observed
on 55 studies that were scored with BI-RADS 3, which obtained a VDG of 4. One
should note that the VDG thresholds were set based on a US radiologist’s assessment
of BI-RADS density. The low agreement and the perceived overestimation might be
caused by the fact that the BI-RADS scoring in this work was done by an European
radiologist. BI-RADS density grades have been suggested to be underestimated accord-
ing to EU standards when compared to US radiologist96. However, further research is
still required to investigate this eﬀect as only a single radiologist participated in the
presented study.
Regarding the validation process, it was a limitation of our study that we had to
exclude cases without reliable breast MRI ﬁbroglandular tissue segmentation. How-
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ever, we do not think this inﬂuenced our results because the causes for rejecting MRI
cases were mostly not related to breast composition. Rejected cases were distributed
evenly for the BI-RADS categories 1, 2 and 3. A higher percentage of rejected cases
was observed on BI-RADS category 4 (8 of 15). This fact is explained by the diﬃculty
of automatically segmenting ﬁbroglandular tissue in breasts with high density in MRI.
One could think that the exclusion of these BI-RADS category 4 cases increases the cor-
relation coeﬃcients between FFDM and MRI measurements. However, these rejected
cases had minor inﬂuence on the complete dataset (3% of the total number of studies).
In conclusion, our study shows that it is feasible to obtain accurate measurements
of absolute and relative volumes of dense breast tissue from full ﬁeld digital mammo-
grams. Availability of such measurements is crucial for the development of objective
breast cancer risk models and may be used in the development of personalized screening
protocols.
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Abstract
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is increasingly
being used for the detection and diagnosis of breast cancer. Compared to mammogra-
phy, DCE-MRI provides higher sensitivity, however its speciﬁcity is variable. Moreover,
DCE-MRI data analysis is time consuming and depends on reader expertise. The aim
of this work is to propose a novel automated breast cancer localization system for
DCE-MRI. Such a system can be used to support radiologists in DCE-MRI analysis by
marking suspicious areas. The proposed method initially corrects for motion artifacts
and segments the breast. Subsequently, blob and relative enhancement voxel features
are used to locate lesion candidates. Finally, a malignancy score for each lesion candi-
date is obtained using region-based morphological and kinetic features computed on the
segmented lesion candidate. We performed experiments to compare the use of diﬀerent
classiﬁers in the region classiﬁcation stage and to study the eﬀect of motion correc-
tion in the presented system. The performance of the algorithm was assessed using
free-response operating characteristic (FROC) analysis. For this purpose, a dataset of
209 DCE-MRI studies was collected. It is composed of 95 DCE-MRI studies with 105
breast cancers (55 mass-like and 50 non-mass-like malignant lesions) and 114 DCE-MRI
studies from women participating in a screening program which were diagnosed to be
normal. At 4 false positives per normal case, 89% of the breast cancers (91% and 86%
for mass-like and non-mass-like malignant lesions, respectively) were correctly detected.
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5.1 Introduction
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) of the breast is
employed for breast cancer screening in women with cumulative lifetime breast cancer
risk of more than 20-25% (US and EU guideline)16. Other indications include, but
are not limited to, preoperative staging, evaluation of women treated with neoadjuvant
chemotherapy and problem solving in case of inconclusive ﬁndings from other modali-
ties. Compared to mammography, which is the image modality commonly used in reg-
ular screening, breast DCE-MRI presents higher sensitivity24, especially in women with
dense breasts23. However, speciﬁcity is more variable, both for screening16 and char-
acterization24 purposes, since the examination of breast DCE-MRI depends on many
factors such as reader expertise and use of adequate visualization techniques. This fact
can lead to a substantial amount of false positive ﬁndings. Furthermore, breast MRI
analysis requires interpretation of four-dimensional DCE data, as well as correlation
to multi-parametric data from other MRI imaging sequences, and is therefore a time
consuming task.
In order to help overcome these limitations, dedicated workstations are currently
used in clinical practice to assist the radiologist in the detection and classiﬁcation of
breast lesions in DCE-MRI data. These systems mainly provide an automated ki-
netic assessment by color-coding the intensity changes per voxel during enhancement
of the breast tissue. This automated assessment aids in the interpretation of patterns
of contrast enhancement (persistent, plateau and washout enhancement) across a series
of MRI volumes30, but human interaction is still required to identify and character-
ize suspicious areas, which increases the risk of misinterpreting or overlooking breast
lesions25,26 and may cause inter- and intra-observer variability31.
A computer-aided detection (CAD) system that marks the most suspicious locations
of the breast can aid radiologists in the analysis of breast DCE-MRI. Such a system
can reduce the interpretation time of analyzing breast DCE-MRI data and, as shown
when CAD has been applied to other modalities97–100, otherwise missed lesions could
be detected.
Only a few authors have presented algorithms to automatically detect lesions in
breast DCE-MRI38–40. The method developed by Vignati et al.38 used subtracted
mean intensity projection images over time, which were normalized using the contrast
uptake of the mammary vessel. Renz et al.39 evaluated a fully automatic CAD sys-
tem that segmented lesions with a hierarchical 3D Gaussian pyramid approach. More
recently, Chang et al.40 combined kinetic and morphological features to identify focal
tumor breast lesions. However, in these previous studies, results were reported for rela-
tively small datasets that do not cover the entire spectrum of malignant breast lesions
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since non-mass-like enhancing lesions, which are lesions with abnormal enhancement
larger than focus without space-occupying eﬀect29, and thus without blob-like shape,
are not included. Therefore, automatic lesion detection in DCE-MRI is still an open
problem. The problem is also clinically relevant since recent studies showed that le-
sions are regularly overlooked or misinterpreted in breast cancer screening programs
with MRI25,26.
In this work, we propose a novel CAD system to automatically detect breast lesions
in DCE-MRI. The system is a multi-stage approach that uses blob features in com-
bination with kinetic and morphological information of the lesion in motion corrected
data. The performance of the algorithm was assessed using free-response operating
characteristic (FROC) analysis, using a dataset composed of 95 studies with manually
annotated malignant mass-like and non-mass-like lesions and 114 studies from patients
participating in a screening program for high and intermediate risk women that were
evaluated as normal.
5.2 Material and methods
5.2.1 Study dataset
The dataset used in this study contained 209 T1-weighted coronal DCE-MRI studies
from diﬀerent patients (age: 22-81 years, mean age: 48.5 years). Of the complete
dataset, 114 DCE-MRI studies were obtained from patients participating in a high-risk
screening program. These MRIs were scored as either BI-RADS 1 (n = 87) or BI-RADS
2 (n = 27). For each included MRI, at least 2 years of follow up were available with
no sign of breast cancer and no previous history of breast cancer or breast surgery was
reported. These patients and their scans are referred to as normal patients and normal
DCE-MRI in the paper.
The remaining 95 DCE-MRI studies contained visible malignant abnormalities, 105
malignant lesions in total, of which 55 were mass-like lesions and 50 were non-mass-
like lesions. For this dataset, the average eﬀective lesion radius was 10.83 mm with a
standard deviation of 6.18 mm and range of 2.50 - 29.78 mm. The malignant lesions
included ductal carcinoma in situ (DCIS), invasive lobular carcinoma (ILC), adenocar-
cinoma, invasive ductal carcinoma (IDC) and ovarian metastases. Of the total number
of lesions included in this study, 26 lesions, with radius size of 9.05 ± 4.73 (mean ±
stdev), were detected in screening examinations with MRI. The remaining 79 lesions,
with radius size of 11.41 ± 6.51, were detected in diagnostic MRI exams performed
in clinical routine, for instance after detection of breast cancer in mammograms or
in symptomatic patients. The distribution of breast cancer lesion types is shown in
Table 5.1.
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Table 5.1: Distribution of breast cancer lesion types included in the study dataset
Mass-like Non-mass like
DCIS 6 22
ILC 11 12
Adenocarcinoma 8 3
IDC 29 12
Ovarian metastasis 1 1
Total 55 50
Breast DCE-MRI image acquisitions were performed on either a 1.5 or 3 Tesla
Siemens scanner (Magnetom Avanto, Magnetom Sonata, Magnetom Simphony and
Magnetom Trio), with a dedicated breast coil (CP Breast Array, Siemens, Erlangen).
All acquisitions were collected from 2003 to 2012. Pixel spacing (from 0.586 mm to 1.33
mm), coronal slice thickness (from 1 mm to 1.5 mm) and 4D volume size ( left-to-right:
[ 256 - 512 ] voxels, superior-to-inferior: [ 128 - 256 ] voxels, posterior-to-anterior [ 72
- 160 ] voxels, and time points: [ 5 - 6 ]) diﬀered among acquisitions. The ﬁrst time
point (𝑇0) was acquired before intravenous agent injection. As indicated by the breast
MRI guidelines from the European Society of Breast Imaging16, the ﬁrst post contrast
time point was acquired around the 90th second after intravenous agent injection and
consecutive time points were acquired every 100 seconds approximately. The contrast
medium was administered at a dose of 0.1 mmol/kg (Medrad, Warrendale, PA) using
a power injector (Medrad, Warrendale, PA) at a ﬂow rate of 2.5 mL/s, followed by a
saline ﬂush.
All lesions were retrospectively annotated by a trained medical doctor experienced
in breast DCE-MRI. The annotated lesions’ location, size and their classiﬁcation into
mass-like or non-mass-like lesion type according to the predominant feature were veri-
ﬁed on the basis of the radiological reports. In case of doubt, a breast radiologist was
consulted. The annotations were performed in an in-house developed dedicated breast
DCE-MRI annotation workstation71 that provided the visualization of DCE-MRI time
sequences, subtraction images and relative enhancement images. A semi-automatic
segmentation algorithm was used to obtain accurate and consistent breast lesion seg-
mentations. This method is a modiﬁed version of the smart opening algorithm initially
developed for nodule and lesion segmentation in CT images101. Smart opening is a
hybrid segmentation approach that combines threshold-based with model-based mor-
phological processing. It has recently also been used in other studies for lesion segmen-
tation in breast DCE-MRI102. Segmentations were made on the subtraction volume of
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the ﬁrst post-contrast acquisition and the pre-contrast acquisition. A subtraction vol-
ume refers to the subtraction of image intensities between two volumes. The annotator
had to provide a seed point roughly in the center of the lesion for the segmentation.
More than one seed point was required to annotate large lesions (mainly non-mass-like
lesions). Figure 5.1 shows a set of lesion segmentation examples.
Figure 5.1: Semi-automatic lesion segmentation examples. Lesion types are (a-b) mass-like DCIS, (c)
non-mass-like ILC and (d) mass-like adenocarcinoma.
5.2.2 Automatic breast lesion detection in DCE-MRI
A general overview of the automatic breast lesion detection method is shown in Fig. 5.2.
The processing algorithm starts by correcting for motion artifacts and segmenting the
breast. Subsequently, an initial stage to locate lesion candidates by combining blob
and relative enhancement voxel features is performed on the breast area. Finally, false
positive reduction is applied in a second stage by incorporating morphological and
kinetic features from the candidate region. These steps are consecutively explained
below.
Figure 5.2: Overview of the presented automatic lesion detection framework in breast DCE-MRI.
Motion correction
Motion correction is applied to remove artifacts from the DCE-MRI data. These arti-
facts are caused by movement of the patient during the image acquisition process and
could inﬂuence the lesion kinetic characteristics. Images at post-contrast time points
(𝑇1 − 𝑇𝑛) are mapped to the pre-contrast acquisition 𝑇0 by using a registration al-
gorithm that combines rigid and non-rigid B-Splines transforms in a multi-resolution
scheme103. Stochastic gradient descent optimizer and mutual information similarity
measure, as signal intensity varies along time, are used. B-Splines grid spacing was set
to 160, 80 and 40 mm for each of the 3 resolutions respectively. A coarse spacing was set
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in order to avoid local volume changes in the region of the enhancing lesion104. Elastix56
was used for the implementation. Figure 5.3 shows an example of a subtraction image
computed before and after applying motion correction.
Figure 5.3: Comparison between subtraction images (a) without and (b) with motion correction for
an axial slice with a visible IDC. The same window and level were used to display these images.
Breast segmentation
The breast is automatically segmented to focus the detection only on the breast tissue,
excluding the chest, the arms and the pectoral muscle, and therefore reduce false positive
ﬁndings. A breast MRI segmentation method that captures the anatomic variation of
the pectoral muscle and chest wall region is applied to the pre-contrast DCE-MRI
volume 𝑇0. The method is based on our previously reported work105. It uses spatial
information provided by probabilistic atlases. A probabilistic atlas is a volume that
contains the complete spatial distribution of probabilities for a voxel to belong to one
or more organs. In this work, three probabilistic atlases are used to have a good
representation of diﬀerences in women with small, medium and large breasts. The size
of the breast is measured as the distance along the anterior-posterior axis between the
anterior of the breast and the coronal plane through the sternum. This distance is noted
as 𝑑𝐴𝑃 (see Fig. 5.4(a)). The large probabilistic atlas is chosen to segment patients with
𝑑𝐴𝑃 larger than 95 mm, the medium atlas for patients with 𝑑𝐴𝑃 between 66 and 95
mm, and the small atlas for patients with 𝑑𝐴𝑃 smaller than 66 mm. Figure 5.4(b)
shows an example of the segmentation obtained by the automatic breast segmentation
approach.
Voxel candidate detection
After segmenting the breast, a voxel candidate detection is applied to select enhancing
voxel candidates for further processing (see Sec. 5.2.2). Since signal intensity enhance-
ment after contrast agent administration is visible in all breast lesions apart from cysts,
these enhancing voxels are suspicious to belong to a breast lesion. A classiﬁer trained
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Figure 5.4: Automatic breast segmentation: axial slice of pre-contrast DCE-MRI volume 𝑇0 with (a)
breast size measured as 𝑑𝐴𝑃 and (b) its breast segmentation.
with labeled voxel data calculates the likelihood of abnormality using voxel features
computed from the relative signal enhancement (𝑅𝑡). The relative signal enhancement
at a speciﬁc time point 𝑡 after contrast agent injection is deﬁned as
𝑅𝑡 =
𝑇𝑡 − 𝑇0
𝑇0
. (5.1)
As the ﬁrst post-contrast time point 𝑇1 is the advocated time point for lesion de-
tection and assessment of morphology on breast DCE-MRI data acquired following the
European guidelines16, 𝑅1 was used in this work for the computation of features.
The ﬁrst features are smoothed 𝑅1 values at diﬀerent scales, which are deﬁned
as 𝑅1(𝜎𝑟) = 𝑅1 ⊗ 𝐺(𝜎𝑟), where ⊗ represents the convolution operator and 𝐺(𝜎𝑟) is
a Gaussian smoothing ﬁlter at scale 𝜎𝑟. With the computation of 𝑅1(𝜎𝑟), artifacts
produced by noise and local deformations not corrected in the motion correction step
are reduced.
The remaining features derive from two diﬀerent blob measures. These blob features
are deﬁned to characterize the shape of bright blob-like structures. These features
were chosen because mass-like breast lesions and most enhancing areas of non-mass-
like lesions appear as bright blobs in relative signal enhancement volumes. The ﬁrst
blob measure 𝐵1(𝜎𝑏), where 𝜎𝑏 represents the size of the blob, is based on the Laplacian
of Gaussian. The second blob measure 𝐵2(𝜎𝑏), which is extensively described in Li et
al.106, uses eigenvalues from the Hessian matrix to characterize blobs. The eigenvalues
are 𝜆1, 𝜆2 and 𝜆3 and satisfy |𝜆1| >= |𝜆2| >= |𝜆3|. The bright blob enhancement
measure used in this work is computed as follows:
𝐵2(𝜆1, 𝜆2, 𝜆3) =
⎧{
⎨{⎩
|𝜆3|2/|𝜆1| if 𝜆1 < 0, 𝜆2 < 0, 𝜆3 < 0,
0 otherwise.
(5.2)
In total, 16 features are used in this stage: 10 𝑅1(𝜎𝑟) at diﬀerent 𝜎𝑟 scales expo-
nentially ranging from 0 to 10 mm, and 6 blob features from computing 𝐵1(𝜎𝑏) and
𝐵2(𝜎𝑏) at 𝜎𝑏 = 3, 10 and 17 mm, respectively. The 𝜎𝑟 and 𝜎𝑏 values were selected to
cover a large range of lesion sizes. An example of blob feature responses can be seen in
Fig. 5.5.
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(a) (b) (c)
Figure 5.5: Response of the blob features (b) 𝐵1(𝜎𝑏) and (c) 𝐵2(𝜎𝑏) with 𝜎𝑏 = 3 mm in an axial
subtracted slice containing an invasive lobular carcinoma.
The random forests classiﬁer107 was used in the voxel candidate detection stage to
compute the likelihood of abnormality map. We chose this classiﬁer as it is considered
a state-of-the-art classiﬁer and it incorporates a type of greedy feature selection as part
of its learning algorithm. The maximum number of trees and the maximum tree depth
were set to 500 and to the number of features used in this stage (n = 16), respectively.
The abnormality likelihood given by the ﬁrst stage was computed by averaging the
output over all the trees.
To train the voxel candidate detection classiﬁer to detect malignant lesions, we
collected 40000 training samples with a ratio of 5 normal samples per abnormal sample.
For the abnormal class, we collected samples within the lesion annotations with the
highest relative signal enhancement 𝑅1 voxel value. For the normal class, we randomly
selected samples from breast voxels on normal cases with 𝑅1 > 0.
Finally, to obtain the lesion candidates that are taken to the ﬁnal detection stage,
local maxima of the voxel likelihood map computed using the previously described
features are determined by means of a spherical kernel (radius = 5 mm). Subsequently,
the highest maxima within a radius of 20 mm are taken as the ﬁnal candidates. We
chose for this two-stage approach and not a single sweep with a 20 mm spherical kernel
to reduce computation time.
Region classiﬁcation
In this ﬁnal step, the likelihood of malignancy of each candidate is computed to obtain
the ﬁnal CAD mark. Firstly, the lesion candidate locations obtained from the previous
stage are used as seed points for an automatic 3-D region segmentation using smart
opening102. As performed for the manual annotation of the lesions (see Sec. 5.2.1),
smart opening is applied on the subtraction of the ﬁrst post-contrast acquisition and
the pre-contrast acquisition. Secondly, morphological and kinetic features are computed
to train a classiﬁer for false positive reduction.
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To characterize lesion morphology, the following features are computed based on
the segmentation of the lesion candidate (see Newell et al.31, Gilhuijs et al.108,109 and
Behrens et al.57 for exact deﬁnitions):
• Volume, in cubic centimeters.
• Margin sharpness and variance, taking inhomogeneity of the margin gradients and
their variance along the margin into account to provide a measure of how well the
lesion is delimited.
• Circularity, deﬁned as the percentage of the lesion’s volume covering the volume
of a sphere with the same volume.
• Irregularity, describing the smoothness of the segmented lesions surface.
• Convexity, calculated by comparing the surface of the convex hull of the segmen-
tation with the actual surface of the segmented lesion candidate.
• Radial gradient analysis, measuring the gradients of the lesion margin pointing
toward the lesion center.
• Eﬀective diameter.
• Degree of elongation.
To characterize the kinetic curve measured at each voxel, four well-established ki-
netic features are used110. These parameters are maximum relative signal enhancement
(ME), time to peak (TTP), uptake rate (UR) and washout rate (WR). Their deﬁnitions
can be found below:
𝑀𝐸 =max(𝑅𝑡 ∶ 𝑡 = 0, ..., 𝑁),
𝑇𝑇𝑃 =𝑡𝑝, time of acquisition 𝑝,
where 𝑝 = argmax
𝑡
(𝑅𝑡)
𝑈𝑅 =𝑀𝐸/𝑇𝑇𝑃
𝑊𝑅 =
⎧{
⎨{⎩
𝑅𝑝−𝑅𝑁
𝑡𝑁−𝑡𝑝 if 𝑝 ≠ 𝑁
0 if 𝑝 = 𝑁.
(5.3)
In total, 25 features are used in the ﬁnal region classiﬁcation step. These include
the likelihood of abnormality of the previous stage, 8 morphology features, the average
and the standard deviation of each kinetic parameter for the entire lesion candidate
extent and the average and the standard deviation of each kinetic parameter measured
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within the most suspicious region of the lesion candidate extent. The most suspicious
region is deﬁned as the 3x3x3 voxel volume that shows the strongest relative signal
enhancement at the ﬁrst post-contrast time point. To train the region classiﬁer, we
used region candidates from MR scans with and without annotated lesions. Manual
annotations were used to assign the training region candidates to either the abnormal
or normal class.
5.2.3 Experimental studies
Evaluation measures
FROC analysis was used to determine the performance of the system based on the
malignancy level obtained for each mark and ground truth annotations. A mark given
by the system was considered a true positive when the manual annotation of a malignant
lesion was hit. When multiple marks hit the annotation of a lesion, the one with
the highest malignancy score was chosen and the rest were discarded. False positive
detections are computed on normal patients in order to evaluate the performance of the
proposed approach when applied to a screening population. FROC analysis was carried
out for all malignant lesions and for mass-like and non-mass-like lesions, individually.
In order to obtain a single performance measure, the mean sensitivity in the range
between 0.1 and 4 false positives per normal case (FPs/case) on a logarithmic scale was
computed as
𝑆(𝑖, 𝑗) = 𝑗ln 𝑗 − ln 𝑖 ∫
𝑗
𝑖
𝑠(𝑓)
𝑓 d𝑓, (5.4)
where 𝑖 and 𝑗 are points that limit the evaluated range, 𝑓 is the number of false positives
per normal case and 𝑠(𝑓) is the lesion sensitivity. The computed measure is proportional
to the partial area under the FROC curve plotted on a logarithmic scale. Using a
logarithmic scale avoids that the measure is dominated by operating points at high
false positive rates.
Statistical signiﬁcance of the performance diﬀerence between pairs of evaluated ap-
proaches was determined by means of bootstrapping111. Cases were sampled with
replacement from the pooled cross-validation set 5000 times. Every bootstrap sample
had the same number of subjects as the study dataset. For each new sample, two FROC
curves were constructed using the likelihood scores yielded by the two methods being
compared. Then, the diﬀerence in mean sensitivity 𝑆 in the range between 0.1 FP/case
and 4 FPs/case △𝑆(0.1, 4) was computed. After resampling 5000 times, 5000 values
of △𝑆(0.1, 4) were obtained. 𝑝-values were deﬁned as the fraction of △𝑆(0.1, 4) values
that were negative or zero. Performance diﬀerences were considered to be signiﬁcant if
𝑝 < 0.05/𝑁 , with 𝑁 the number of comparisons performed for Bonferroni correction.
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Study design
In this study, the use of diﬀerent classiﬁers in the region classiﬁcation stage and the
inﬂuence of the motion correction step in the ﬁnal detection results were investigated.
To obtain unbiased detection results, a 5-fold cross-validation was performed at patient
level. The 209 subjects of the study dataset (114 normal and 95 with annotated ma-
lignant lesions) were randomly assigned to each fold. We took care that the number
of malignant lesions was approximately the same for all the folds. For each fold, the
corresponding training set was used to train the voxel classiﬁer of the ﬁrst stage and to
obtain training lesion candidates after applying the aforementioned trained classiﬁer.
Subsequently, the region classiﬁer was trained. The features of this stage were com-
puted on the training lesion candidates. Finally, the complete system was applied to
the test set corresponding to the current fold.
In the ﬁrst experiment, lesion detection was performed using ﬁve diﬀerent classiﬁers
in the ﬁnal region classiﬁcation stage. Optimization of the parameters was carried out
by means of grid search on a nested 5-fold cross-validation within the fold’s training
set. The evaluated classiﬁers were:
1. Linear discriminant analysis classiﬁer (LDA).
2. 𝑘-nearest neighbors classiﬁer (kNN): The grid search was performed on 𝑘 values
of 25, 50, 100, 150 and 175.
3. Gentleboost classiﬁer (GB): For the gentleboost classiﬁer112, regression stumps
were used as weak learners. The explored number of regression stumps were 50,
100, 500 and 1000.
4. Support vector machine classiﬁer with radial basis function kernel (SVM): LIB-
SVM113 was used for its implementation. Cost 𝐶 and kernel scale 𝛾 were opti-
mized. 𝐶 was varied by 2𝑖, with 𝑖 between -4 and 4 with a step of 2, and 𝛾 was
varied by 2𝑗, with 𝑗 between -15 and 15 with steps of 5. Probability estimates
were generated with LIBSVM following the approach of Wu et al.114.
5. Random forests classiﬁer (RF): 50, 100, 500 and 1000 maximum number of trees
were explored by the grid search optimization process. The maximum depth of
the tree was set to the number of features (n = 22). The malignancy likelihood
given by the classiﬁer was computed by averaging the output over all the trees.
The mean sensitivity in the range between 0.1 and 1 FPs/case, 𝑆(0.1, 1) was used as
an optimization measure. The parameters that resulted in the highest 𝑆(0.1, 1) value
averaged over all inner ﬁve folds were chosen to detect lesions in the outer testing fold.
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The second experiment was performed to investigate the beneﬁt of applying motion
correction to the data. Following the same nested 5-fold cross-validation procedure used
in the previous experiment, the presented CAD was trained and tested on the study
dataset with and without applying motion correction.
5.3 Results
Results of the ﬁrst experiment can be observed in Fig. 5.6, which shows the performance
of the proposed CAD system using diﬀerent classiﬁers in the ﬁnal region classiﬁcation
stage. Table 5.2 shows 𝑝-values for the comparisons between the classiﬁers. For the
detection of malignant lesions, LDA, kNN, gentleboost, SVM and random forests ob-
tained mean sensitivity values in the range between 0.1 and 4 FPs/case of 0.48, 0.60,
0.66, 0.64 and 0.72, respectively. The random forests classiﬁer outperformed the other
classiﬁer techniques achieving an overall sensitivity of 0.55, 0.78, 0.89 and 0.95 at 0.1,
1, 4 and 7 false positives ﬁndings on normal patients, respectively. The sensitivities
for MRI screen-detected lesions and for lesions detected in MRI after referral from
other modalities were 0.46, 0.69, 0.81 and 0.89, and 0.58, 0.81, 0.91 and 0.96 at 0.1,
1, 4 and 7 FPs/case, respectively. Considering that 10 pairwise comparisons between
diﬀerent classiﬁers were performed, the random forests classiﬁer obtained signiﬁcantly
better performance than LDA and kNN (𝑝 = 0.001 and 𝑝 < 0.001, respectively). The
performance of the initial voxel candidate detection stage is also presented in Fig. 5.6.
Figure 5.6: FROC curves of the presented CAD system using diﬀerent classiﬁers in the region classi-
ﬁcation stage.
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Table 5.2: 𝑝-values obtained when comparing the performance of diﬀerent classiﬁers in the region
classiﬁcation stage. Signiﬁcant diﬀerences are indicated with a star (*).
LDA kNN GB SVM RF
LDA - 0.002* <0.001* <0.001* 0.001*
kNN - - 0.067 0.042 <0.001*
GB - - - 0.679 0.037
SVM - - - - 0.011
RF - - - - -
Figure 5.7 shows some examples of lesions detected by our CAD system using ran-
dom forests in the region classiﬁcation stage. Examples of false positive detections in
normal patients can be observed Fig. 5.8.
In the second experiment, the presented CAD system was trained and tested on
the study dataset with and without applying motion correction. The random forests
classiﬁer was used in the region classiﬁcation stage. The FROC curves obtained for
the detection of all malignant, mass-like malignant and non-mass-like malignant lesions
are shown in Fig. 5.9. The use of motion correction signiﬁcantly improved the overall
performance of the system to detect breast cancer (𝑝 = 0.023) reaching a sensitivity
for the detection of mass-like and non-mass-like malignant lesions at 0.1, 1, 4 and 7
FPs/case of 0.67, 0.85, 0.91 and 0.96, and 0.42, 0.7, 0.86 and 0.92, respectively. As
visible in the FROC curve of Fig. 5.9(c), motion correction has a larger impact in the
detection of non-mass-like malignant lesions (𝑝 = 0.004). Figure 5.10 shows a DCIS that
was detected at 0.38 FPs/case when motion correction was applied. Without motion
correction, the lesion shown in Fig. 5.10(a) was missed by the system.
5.4 Discussion
In this work, we developed a CAD system for breast cancer in DCE-MRI that provides
automated localization of malignant lesions on motion corrected data. First, relative
enhancement and blob features are used to detect suspicious areas. Then, the ﬁnal
malignancy likelihood is obtained using region-based morphological and kinetic infor-
mation computed on segmented lesion candidates. The use of diﬀerent classiﬁers in the
ﬁnal region classiﬁcation stage and the eﬀect of applying motion correction were inves-
tigated. A large dataset of 209 DCE-MRI studies from diﬀerent women composed of 95
DCE-MRI volumes with 105 annotated mass-like and non-mass-like malignant lesions,
and 114 DCE-MRI volumes from normal screening patients was used to evaluate the
algorithm when applied to a screening population.
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Figure 5.7: Lesions detected by the proposed CAD system on axial subtracted images at the ﬁrst
post-contrast time point. The squared markers represent the lesion candidates given by the proposed
algorithm.
An overall sensitivity of 0.55, 0.78, 0.89 and 0.95 at 0.1, 1, 4 and 7 false positives
ﬁndings on normal patients, respectively, was achieved for the detection of malignant
lesions. The mean sensitivity in the range between 0.1 and 4 FPs/case was 0.72. The
best results were obtained using random forests in the ﬁnal region classiﬁcation stage.
The random forests classiﬁer outperformed LDA, kNN, gentleboost and SVM. This
improvement in performance was signiﬁcant when random forests were compared to
LDA and kNN. The performance of the CAD was also evaluated for the detection
of mass-like and non-mass-like lesions separately. The sensitivity for the detection of
mass-like malignant lesions was 0.67, 0.85, 0.91 and 0.96 was obtained at 0.1, 1, 4 and
7 FPs/case, respectively. The performance was lower for the detection of non-mass-like
malignant lesions: 0.42, 0.7, 0.86 and 0.92 at 0.1, 1, 4 and 7 FPs/case. The sensitivity
for the detection of lesions detected in MRI after referral from other modalities (0.58,
0.81, 0.91 and 0.96 at 0.1, 1, 4 and 7 FPs/case), as expected, was higher than the
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(a) (b)
(c) (d)
Figure 5.8: False positive detections on axial subtracted images of 4 diﬀerent normal patients. The
squared markers represent the lesion candidates given by the proposed CAD system.
sensitivity obtained for the detection of screen-detected lesions (0.46, 0.69, 0.81 and
0.89, at 0.1, 1, 4 and 7 FPs/case). This is explained by the fact that the former
includes larger lesions, which is in line with the ﬁndings in symptomatic patients115.
To date, only a few studies on automatic breast lesion detection in DCE-MRI are
found in the literature38–40. Results for the detection of malignant lesions were 0.98 at
4 FP per breast38, 0.98 at 0.16 FPs/case39 and 1 at 6.30 FP/case40. Care should be
taken when comparing the presented results to the results reported in these previous
studies, since diﬀerent datasets were used and diﬀerent evaluation procedures were
followed. For instance, false positive detections were not computed on normal cases
from women participating in a high-risk screening program38–40, but only computed
false positive marks as detections in other locations than the apparent cancer in women
with a lesion on the MRI scan. Note that under a screening setting, only the normal
cases are relevant when assessing the false-positive detections. Furthermore, ground
truth annotations were not provided in Renz et al.39 and in Chang et al.40, but their
evaluation was based on the visual inspection of the ﬁndings detected by the system.
In Vignati et al.38 and in Renz et al.39, FROC analysis was not performed. Finally,
only mass-like lesions were considered in Vignati et al.38 and in Renz et al.39. Chang
et al.40 do not clearly describe whether non-mass-like lesions were also included in their
evaluation dataset.
The detection of non-mass enhancement is important as a large proportion of rel-
evant lesions present as non-mass-like enhancement. In practice, 20 to 30 % of all
invasive cancers present as non-mass-like enhancement116. Moreover, the vast majority
of DCIS lesions presents as non-mass-like enhancement. While it is known that DCIS
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Figure 5.9: FROC curves yielded by our CAD system with and without motion corrected data for (a)
all malignant, (b) mass-like malignant and (c) non-mass-like malignant lesions.
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Figure 5.10: A DCIS detected at lower false positive rate by the CAD system when motion correction
was applied. The same window and level were used to display these axial subtracted images. Lesion
is pointed by an arrow on the motion corrected example. Due to motion, the relative enhancement of
healthy breast parenchyma can appear as enhancing structures that can confuse the CAD system both
in training and testing. This is illustrated in the left part of the image (a). Additionally, motion can
introduce spurious edges in lesion morphology (see lesion in (a)). Both issues are reduced by motion
correction (b).
is not harmful at this stage due to its noninvasive form, evidence suggests that DCIS
lesions may progress to invasive carcinomas if they are left untreated117. MRI is par-
ticularly useful for the detection of high grade DCIS, that is known to progress faster
to invasive disease than low grade DCIS118, and usually also presents as non-mass-like
enhancement on MRI.
In this work, we also studied the eﬀect of motion correction in terms of automatic
detection of breast cancer. We showed that applying motion correction to DCE-MRI
data improved the performance of our CAD system. This beneﬁt is mainly observed for
the detection of non-mass-like lesions, which have more irregular shapes. We observed
that the enhancement pattern visible on non-mass-like lesions is more uniform on motion
corrected data, which facilitates the segmentation of the lesion candidates and the
computation of kinetics and morphological features. In our experiments, we did not
observe this eﬀect on mass-like lesions as the shape and the enhancement of this type
of lesions were not strongly altered by motion artifacts. However, we believe that
there is still room for improvement as a B-Splines registration algorithm with a coarse
grid spacing was used in this work. The eﬀect of using a ﬁner grid spacing and/or
other motion correction algorithms that account for smaller deformations remains to
be investigated.
The ﬁrst post-contrast time point was used to compute relative enhancement and
blob features in the voxel candidate detection stage. The ﬁrst post-contrast time point
was chosen because, considering the protocol used to acquire the study dataset, this
is the advocated time point for lesion detection and assessment of morphology16. One
should note that protocols for performing breast DCE-MRI may substantially vary
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among centers, due to the equipment being used and the clinicians’ preferences. The
use of a diﬀerent time point might be required when applying the proposed CAD system
to data acquired in other centers, or ideally, speciﬁc algorithms could be developed to
estimate the contrast arrival time and select the most appropriate time point, which
would not imply any modiﬁcation in the proposed framework.
Regarding the evaluation of this work, it is important to note that the aim of our
detection algorithm is to locate suspicious lesions in order save interpretation time and
avoid overlooking errors. For this reason we used BI-RADS 1 and 2 cases as normal
cases in our training and testing. These lesions were identiﬁed by our radiologists as
obviously benign. All biopsy proven malignant lesions were included as true positive
training and test samples. It is debatable whether biopsied benign BI-RADS 3 or
higher lesions should be considered as true or false positives, since they are suspicious
lesions that require further investigation. This is why we left them out both in our
training set as well as in our test set. Further classiﬁcation of the lesions detected by
the presented system into benign or malignant could be performed using existing lesion
characterization techniques31,110,119,120.
Further research will focus on improving the performance of the presented algorithm
at a low false positive rate. We observed that the use of only one seed for lesion seg-
mentation may produce less accurate results, which would inﬂuence the computation
of morphological and kinetic features. This eﬀect was specially visible in non-mass-like
lesions. We believe that a more accurate lesion segmentation algorithm can help to
improve the overall performance of our algorithm. In order to do so, similar to the
procedure followed in this work to obtain manual annotations, techniques can be de-
veloped to identify candidates belonging to the same lesion and, therefore, apply smart
opening on multiple seeds. Other breast lesion segmentation techniques will also be in-
vestigated: a lesion segmentation approach based on Fuzzy C-Means121, a multichannel
Markov Random ﬁeld framework122 and a spiral-scanning method previously applied
to 3D Automated Breast Ultrasound (ABUS) images for the segmentation of breast
lesions123. Alternatively, the use of other breast segmentation algorithms41,42,64,124 will
be studied as two lesions were missed due to breast segmentation errors.
5.5 Conclusion
In this paper we have presented a fully automatic algorithm for the detection of breast
cancer in DCE-MRI. We introduced blob features in an initial voxel candidate detection
stage. Morphological and kinetic features are employed by a second step to reduce false
positives. Evaluation on a dataset of 209 DCE-MRI cases, which contained 114 DCE-
MRI studies representative for normal patients participating in a screening program,
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showed that our approach yields high sensitivity for the detection of malignant lesions
at an acceptable number of false positives: 0.55, 0.78, 0.89 and 0.95 at 0.1, 1, 4 and 7
false positives ﬁndings on normal patients, respectively. While the appropriate oper-
ative point has to be determined experimentally, we are conﬁdent that the presented
algorithm has the potential to support radiologists during the analysis of DCE-MRI
data by automatically prompting suspicious areas.
Automated detection of breast cancer in prior
false-negative screening MRI
6
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6.1 Introduction
Breast Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) has been
used for almost 15 years17,125–128 as a screening imaging modality in patients with
high risk for developing breast cancer. DCE-MRI has shown to be more sensitive to
detect breast cancer than mammography17–22, especially in women with dense breasts58.
Nowadays, breast DCE-MRI is recommended in screening programs for women with
cumulative lifetime breast cancer risk of more than 20-25% (US and EU guidelines)15,16.
Screening allows the retrospective analysis of observer errors. Retrospective studies
in mammography100,129–133 revealed that observer errors were frequent. Based on the
results of these studies, it could be estimated that 20%-30% of cancers could be detected
earlier in screening without an increase in the recall rate to an unacceptable level134.
Only a few similar but smaller studies into observer error have been performed
in breast MRI25,26. These studies investigated the causes of false-negatives results
on prior DCE-MRI studies in patients who developed breast cancer as revealed on
a follow-up or incident round of screening MRI25,26. In the retrospective evaluation
of Pages et al.25, 58 pairs of prior and diagnostic MR imaging studies (60 cancers)
were assessed. Of these 60 cancers, the authors reported potential observer error in 28
(47%) cancers. Similarly, Yamaguchi et al.26 reviewed 16 incident breast cancers in 15
patients screened with MRI. Of these 16 breast cancers, 9 (56%) were identiﬁable on
the prior MRI. Main causes for overlooked or misinterpreted lesions were small lesion
size, extensive background enhancement and malignant lesions with smooth margins,
which is typically found in benign diseases.
These numbers indicate the importance of the development of additional tools to
aid radiologists analyzing DCE-MRI. Although it has not been reported, it is evident
that fatigue or lack of experience while analyzing 4-dimensional data are also other
factors for observer error. A computer-aided detection (CAD) system that prompts
suspicious regions could draw the attention of the radiologist to a tumor that might be
otherwise overlooked, or to an abnormal region in the image that would require careful
interpretation. Computer-aided detection systems are currently being developed for
this purpose38–40.
The aim of this study is to evaluate the potential use of a CAD system to detect
breast cancer which was overlooked or misinterpreted in a breast screening program
with MRI. To this purpose, we applied the CAD system that we have developed in
this thesis (see Chapter 5) on prior DCE-MRI scans with cancer lesions that were
prospectively detected on an incident round of screening.
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6.2 Materials and methods
6.2.1 Case selection
This retrospective study was approved by our institutional board and the requirement
for informed consent was waived. A cross computer search of our MR imaging records
and our pathology records identiﬁed, between January 2003 and December 2013, a total
of 573 patients with invasive cancers and 78 with in situ carcinomas. In 42 of these
patients (36 with invasive, 5 with in situ carcinomas and 1 with both), there was a
prior DCE-MRI examination performed between 6 - 24 months before the one where
the cancer was diagnosed. The mean time interval between prior and diagnostic DCE-
MRI studies was 11.9 ± 3.31 months. We only considered prior DCE-MRI studies with
a Breast Imaging Reporting and Data System (BI-RADS) score of 1, 2, or 3. We also
included a cancer which was scored with BI-RADS 0 on the prior MRI but BI-RADS
2 was given after an additional 3D ultrasound that was performed on the same day.
In total, 44 tumors that constituted the study group were present in these 42 patients.
All included patients were women between the ages of 33 and 78 years (mean age 50
± 9.71 years). The indications for performing breast DCE-MRI examination included
high risk screening due to prior breast cancer (10 patients), positive family history of
breast cancer (30 patients, 22 patients with BRCA mutations), estrogen therapy (1
patient) or solving problems after conventional imaging (1 patient).
6.2.2 DCE-MRI imaging technique and retrospective interpretation
The DCE-MRI examinations in this study were performed on 1.5 or 3T Siemens scanner
(Magnetom Avanto, Magnetom Sonata, Magnetom Simphony or Magnetom Trio) by
using a dedicated bilateral breast surface coil. Patients were placed in prone position.
A transverse or coronal three-dimensional T1-weighted gradient-echo (GRE) dynamic
sequence was performed before contrast agent administration followed by 4 or 5 post
contrast sequences. Pixel spacing (from 0.664 mm to 1.5 mm), slice thickness (from
1 mm to 1.5 mm), matrix (256×128, 384×192, 448×381 or 512×96 pixels), echo time
(from 1.71 msec to 4.76 msec), repetition time (from 4.56 msec to 8.41 msec) and ﬂip
angle (from 10∘ to 25∘) diﬀered among acquisitions. The ﬁrst time point was acquired
before intravenous contrast agent injection. The ﬁrst post contrast acquisition started
within the ﬁrst 2 minutes after intravenous contrast agent injection and consecutive time
points were acquired every 100 seconds approximately16. The contrast medium was
administered at a dose of 15 mL or 30 mL using a power injector (Medrad, Warrendale,
PA) at a ﬂow rate of 2.5 mL/s, followed by a saline ﬂush.
The DCE-MRI studies were retrospectively evaluated by a trained technical physi-
cian with expertise in breast MR imaging in an in-house developed dedicated breast
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DCE-MRI annotation workstation71. The workstation provided the visualization of
subtracted images, their maximum intensity projection and T1-weighted images for all
the times points of prior and diagnostic DCE-MRI studies. Figure 6.1 shows an exam-
ple. For each lesion of the diagnostic MR examinations, a manual segmentation was
made and the morphological and enhancement characteristics using the BI-RADS MR-
lexicon29 were given. Simultaneously, the prior MR examination was analyzed. If the
lesion was detected, its level of visibility in the prior MRI was scored as “minimal sign”
or “visible” and the manual segmentation and the BI-RADS lexicon report were also
given. Annotations and BI-RADS assessment were performed using motion corrected
data (see Sec. 5.2.2).
Figure 6.1: Workstation used in this study for lesion annotation and BI-RADS lexicon reporting in
diagnostic (upper row) and prior (lower row) DCE-MRI studies.
Of the 44 retrospectively reviewed lesions, 13 were annotated as not visible, 15 as
minimally visible and 16 as visible in the prior DCE-MRI. Figure 6.2 shows an example
of each category.
6.2.3 Application of CAD on false-negative studies
In this work, the CAD system described in chapter 5 was applied to the 42 prior DCE-
MRI scans of the study dataset. In short, the CAD initially corrects for motion artifacts
and segments the breast. Subsequently, lesions candidates are detected using relative
enhancement and texture features that include blob descriptors. The ﬁnal classiﬁcation
is performed using region-based morphological and kinetic features computed on seg-
mented lesion candidates. Scans of the patients included in this study were not used to
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Figure 6.2: Subtracted images with breast cancer lesions which are (a) visible, (b) minimally visible
and (c) not visible on the prior DCE-MRI study. BI-RADS scores were 1 and 4, 2 and 5, and 1 and 3
for prior and diagnostic of (a), (b) and (c), respectively
train the CAD system.
Of the 42 prior DCE-MRI studies, CAD markers were obtained on 41 cases (31 le-
sions). The CAD system failed to process one case which had very deviating anatomical
characteristics due to thorax deformation and scoliosis (see Fig. 6.3). During MR ac-
quisition, the disease caused the patient lying in a diﬀerent position than the assumed
by the CAD system to process the image resulting in a failure in the breast tissue
segmentation. This case was excluded from the evaluation.
We studied the detection performance of visible or minimally visible lesions in false-
negative DCE-MRI studies. A false-negative DCE-MRI study was deﬁned as a prior
DCE-MRI examination with breast cancer visibility rated as minimal sign or visible.
The detection performance was evaluated using Free-Response Operating Characteris-
tics (FROC) analysis. A ﬁnding detected by the system was considered a true positive
when its center was located inside the manual lesion annotation. False-positive de-
tections were computed on normal breasts. In this study, these were breasts without
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Figure 6.3: Prior DCE-MRI study of a patient with post-polio scoliosis and thorax deformation.
reported malignant disease in prior and diagnostic DCE-MRI scans. Mean sensitiv-
ity and 95% conﬁdence interval (CI) from 0 to 10 false-positives per normal breast
(FPs/breast), with steps of 0.05, were determined using bootstrapping111 to build the
FROC curves. Cases were sampled with replacement from the pooled cross-validation
set 5000 times. Every bootstrap sample had the same number of subjects as the study
dataset. For each new sample, the FROC curve was constructed using the likelihood
scores yielded by the CAD system. Then, the sensitivity at the given FPs/breast point
was computed. After resampling 5000 times, 5000 values of sensitivity at the given
FPs/breast point were obtained.
6.3 Results
Figure 6.4 shows the performance of the CAD system when applied to false-negative
DCE-MRI studies. FROC curves for the detection of visible and minimally visible
and all lesions are illustrated. Mean sensitivity of the CAD system measured with
bootstrapping was 0.63 (95% CI = 0.36 - 0.88) and 0.19 (95% CI = 0.00 - 0.43) at
2 FPs/breast for visible and minimally visible lesions, respectively. Mean sensitivity
was 0.43 (95% CI = 0.24 - 0.61) for the detection of all these lesions combined. At 1
FPs/breast, mean sensitivity was 0.44 (95% CI = 0.15 - 0.75), 0.04 (95% CI = 0.00
- 0.31) and 0.25 (95% CI = 0.07 - 0.50) for visible, minimally visible and all lesions,
respectively. Figure 6.5 shows some examples of lesions which were retrospectively
reported as minimally visible or visible in the prior DCE-MRI study and were detected
by the CAD system.
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Figure 6.4: FROC curves of the CAD performance when applied to prior DCE-MRI studies with
minimal sign and visible breast cancers.
6.4 Discussion
In this study, we evaluated the performance of an automated CAD system when applied
to screening DCE-MRI studies with misinterpreted or overlooked breast cancer. A
dataset of 41 pairs of prior and diagnostic DCE-MRI studies with detected breast
cancer was used. In a retrospective review of these cases, we found that 16 and 15
breast carcinomas were visible and minimally visible, respectively, in the prior DCE-
MRI scan. Results indicate that 63% of the visible and 19% of the minimally visible
lesions were detected by our CAD system at 2 false-positives per normal breast.
Although it is not clear which number of false-positives per study is required for
a computer-aided detection system to be eﬀective, these numbers indicate that an
important amount of overlooked or misinterpreted cancers could have been detected if
a CAD system such as ours would have marked early malignant signs to the screening
radiologists. Large scale experiments need to be set up to determine an appropriate
setting. However, we believe that 2 false positive per breast (4 false positives per study
or volume) could be acceptable as we are dealing with volumetric data that represents
both breasts in a single volume. Note that commercial mammography and chest x-
ray CAD systems have about 1-3 marks per case135,136 and 0.5-2 marks per image137,
respectively.
Further research needs to be conducted to ﬁnd out what the causes were for the
false-negative judgments of the radiologist who interpreted the original scans. Obvi-
ously, this is diﬃcult to do retrospectively. In previous studies, a panel of experts was
used to classify false-negative ﬁndings in prior DCE-MRI studies with cancer revealed
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Figure 6.5: Subtraction images with breast cancer lesions (a-b) minimally visible and (c-f) visible on
prior DCE-MRI studies. These lesions were automatically detected by the CAD system.
on follow-up DCE-MRI. Lesion types were classiﬁed according to BI-RADS lexicon
MRI29 and diagnostic errors were categorized as mismanagement, misinterpretation or
oversight25,26. In future studies we will also investigate the performance of the CAD
system according to lesion types and/or diagnostic errors.
It is important to note that the overall performance of the CAD system might
improve by speciﬁcally training on misinterpreted or overlooked lesions. These cases,
which can be considered as diﬃcult, were not included in the training phase of the CAD
system used in this study.
In conclusion, a computer-aided detection system has the potential to automatically
detect lesions misinterpreted or overlooked in a screening program with MRI for breast
cancer. The integration in clinical practice of such a system may aid the radiologist to
avoid reading errors.
Summary and discussion
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Breast cancer is the most common cause of death among women, worldwide1. Since
early detection increases the chance of survival, many countries have introduced breast
cancer screening programs. In regular breast cancer screening programs, asymptomatic
women are periodically invited for a mammographic examination. However, mam-
mography has its limitations as tumors can get obscured by the presence of dense
tissue10,58,76. Density has been also identiﬁed as a risk factor for developing breast
cancer10. Other risk factors that are associated with increased risk are family history
of breast cancer and the presence of a germ-line mutation of the BRCA1 or BRCA2
gene13,14.
An approach to overcome these shortcomings and optimize breast cancer screening is
the introduction of personalized screening11. In personalized breast screening programs,
women with high risk for developing breast cancer are screened with a complementary
modality. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) has
shown potential as a breast cancer screening tool for this high risk population. Com-
pared to mammography, DCE-MRI has higher sensitivity17–22, especially in women
with dense breasts23. Moreover, MRI is particularly useful for the detection of high
grade ductal carcinoma in situ (DCIS), that is known to progress faster to invasive
disease than low grade DCIS118. However, the analysis of breast MRI data requires
interpretation of four-dimensional DCE data, as well as correlation to multi-parametric
data from other MRI imaging sequences, and is therefore a time consuming task. Fur-
thermore, recent studies reported potential observer errors due to misinterpretation or
oversight of breast cancer lesions that were visible on a follow-up or incident round of
screening MRI25,26.
This thesis focuses on the automated analysis of breast MRI since automated image
analysis techniques and computer-aided detection systems are required to improve the
clinical workﬂow and aid radiologist for reading and interpreting MRI images.
Chapter 2 reports on the development of two fully automated methods for to seg-
mentation of the pectoral muscle in breast MRI. The identiﬁcation of the pectoral
muscle is an important step in methods for automatic breast cancer assessment. Two
possible applications are the delineation of the boundary between body and breast,
which is the most challenging task to segment the breast due to large shape variations
across patients, and the use of pectoral muscle as a reference tissue for pharmacokinetic
modeling. The proposed segmentation methods take into account the 3-dimensionality
nature of breast MRI and are based on atlas-based methodology: a probabilistic and a
multi-atlas approach. Both methods were evaluated on the same dataset. The multi-
atlas framework slightly outperformed the probabilistic (mean DSC values of 0.74±0.06
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and 0.72 ± 0.09, respectively) but the computation time was 14 times larger.
The main limitation of the probabilistic atlas approach is the use of a single reference
atlas. When the image being segmented diﬀers considerably from the reference atlas
and the registration can not compensate the diﬀerences in shape, the ﬁnal segmentation
becomes aﬀected with slightly poorer results. In order to take advantage of the larger
number of atlases available in the multi-atlas approach without considerably increasing
the computation time of the probabilistic atlas framework, a multi-probabilistic altas
approach was proposed. This multi-probabilistic atlas framework, which has been ap-
plied in the studies described in chapters 4 and 5, uses three probabilistic atlases which
were built to represent three diﬀerent populations considering the size of the breast.
Fifty-three manually segmented DCE-MRI studies were used for atlas construction.
Although a substantial improvement in segmentation performance was observed using
the multi-probabilistic atlas algorithm compared to using a single probabilistic atlas,
poorer quality segmentation results due to large diﬀerence in shape between target im-
age and the selected reference atlas were also found. Results suggest that the increase
of number of atlases to cover a larger range of shape variability among patients has the
potential to produce more consistent results. Moreover, other shape diﬀerences among
patients and patient information, such as weight, length, and age, could be considered
to construct the atlases of each represented women population.
In chapter 3, an automated method to segment the breast and estimate breast den-
sity in breast MRI is described. Other image processing techniques that are required
to perform this task, such as image normalization, bias ﬁeld correction and sternum
landmark detection, are also explained. The breast is segmented by automatically
identifying the breast-body and the breast-background boundaries. The breast-body
boundary segmentation is achieved using the probabilistic atlas approach described in
chapter 2. Two-dimensional region growing is applied to segment the breast-background
boundary. Subsequently, the breast volume of each breast is redeﬁned using curvature
and landmark detection to exclude fatty tissue areas that are not part of the breast and
are not visible in mammographic scans. By doing so, breast density measurements com-
puted on MRI are comparable to breast density estimates obtained from mammography.
Finally, breast density is independently computed for each breast using Expectation-
Maximization algorithm and skin-fold removal. Results show high agreement between
automatic breast and breast density segmentations and manual segmentations obtained
from experts. For breast segmentation, we achieved a mean DSC value of 0.94 ± 0.04
and a mean total overlap of 0.96 ± 0.02. For the automatic ﬁbroglandular tissue seg-
mentation, we obtained a mean DSC value of 0.80 ± 0.13.
A slightly modiﬁed version of the developed breast segmentation and breast density
estimation method is used in chapter 4 to validate Volpara 1.4.3 (Mātakina, Welling-
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ton, New Zealand), which is a commercially available method for assessing volumetric
breast density on FFDM. Volumetric estimates obtained with Volpara from FFDM im-
ages were compared to volume estimates obtained from corresponding breast MRI data
of the same patient. To that purpose, our developed method was applied to a dataset
of 250 MRI scans. A radiologist with expertise in breast imaging carefully reviewed all
slices of the segmentations and approved 186 (74.4%) MRI studies with segmentations
to be suitable for the use as a reference standard for validation of FFDM density mea-
surements. Volumetric breast density and breast tissue volume values obtained with
Volpara present high correlation when compared to MRI measurements (correlation val-
ues per breast and per study of 0.91 and 0.93, respectively). This ﬁnding demonstrates
that it is feasible to obtain accurate measurements of absolute and relative volumes of
dense breast tissue from full-ﬁeld digital mammograms. Availability of such measure-
ments is crucial for the development of objective breast cancer risk models and may be
used for stratiﬁcation of women into personalized breast cancer screening protocols.
Although satisfactory results were obtained with the segmentation methods devel-
oped in this thesis, for demanding applications, breast segmentation should be further
improved. The main reasons for poor performance were, in addition to the previously
explained issues related to atlas segmentation, images with small ﬁeld of view where the
breast was not fully covered, and the presence of artifacts and bias ﬁeld after correction.
As it will be discussed later in this chapter, some of these errors could be solved by
the implementation of automated image quality assessment systems that guarantee a
minimum image quality criteria. Alternatively, intra- and inter-patient signal intensity
variability in DCE-MRI could be improved. Normalization methods based on separat-
ing the image into diﬀerent frequency bands138, the development of dedicated breast
MRI bias ﬁeld correction algorithms and ﬁnding the best parameters of existing bias
ﬁeld algorithms67 for their application to breast MRI are some alternatives.
Chapter 5 provides the description of a Computer-Aided Detection (CAD) system
to automatically detect breast cancer in DCE-MRI. The CAD system corrects for mo-
tion artifacts and automatically segments the breast. Subsequently, lesion candidates
are detected using relative enhancement and texture features that include blob descrip-
tors. The ﬁnal classiﬁcation is performed using region-based morphological and kinetic
features computed on segmented lesions candidates. The performance of the system
for the detection of mass-like and non-mass-like lesions is evaluated. Breast cancer is
detected at high sensitivity with an acceptable number of false-positive ﬁndings: 0.55,
0.78, 0.89 and 0.95 at 0.1, 1, 4 and 7 false-positives ﬁndings on normal patients. We
also observed that motion correction is needed to achieve the best CAD system perfor-
mance. Overall, the obtained results are promising to support radiologists during the
analysis of DCE-MRI data by automatically prompting suspicious areas.
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In order to improve the developed CAD system, future work can be focused on
achieving higher performance and decrease the number of false-positives. The second
step of the described CAD system was used to diﬀerentiate between breast lesions and
normal enhancing tissue by computing region-based morphological and kinetic features
on the segmented candidate lesion. We observed that the lesion segmentation algorithm
used for this task produced less accurate results in larger irregular lesions, which inﬂu-
ences the computation of morphological and kinetic features. We believe that a more
accurate lesion segmentation algorithm can help to improve the overall performance
of our algorithm. Other lesions segmentation algorithms can be investigated, such
as a lesion segmentation approach based on Fuzzy C-Means121 and a spiral-scanning
method previously applied to 3D Automated Breast Ultrasound (ABUS) images for the
segmentation of breast lesions123. Furthermore, the use of pharmacokinetic modeling
parameters to characterize breast lesions can be investigated139. In the experiments de-
scribed in chapter 5, we also found that 2 out of 105 lesions were missed due to breast
segmentation errors. The CAD system excludes from the analysis all the voxels located
outside the breast segmentation. We believe that the breast segmentation algorithm
can be improved with the points described above. Alternatively, the use of other breast
segmentation algorithms41,42 can be considered.
In chapter 6, we studied the potential of our CAD system to detect breast cancer
which was overlooked or misinterpreted in a breast screening program with MRI. A
dataset of 41 pairs DCE-MRI studies was collected. Each pair was composed of a prior
DCE-MRI and an incident or follow-up DCE-MRI study where the breast cancer was
diagnosed. In a retrospective review of these cases, we found that 16 breast cancers were
visible and 15 were minimally visible in the prior DCE-MRI scan. Our CAD system
detected 63% of the visible and 19% of the minimally visible lesions at 2 false-positives
per breast. These results suggest that the integration in clinical practice of such a
system may aid the radiologist to avoid reading errors.
Finally, it should be noted that all the methods described in this thesis have been
developed and evaluated using data collected in only one clinical center. Therefore, ro-
bustness against diﬀerences in population and image acquisition systems have not been
investigated. However, we are conﬁdent that, with minor adjustments, the proposed
methods are suitable for application to datasets obtained in diﬀerent institutions and
under diﬀerent conditions, since our datasets contained images obtained on diﬀerent
scanners with diﬀerent clinical imaging protocols. Furthermore, since these methods
have been developed taking the anatomy of the women into account, we believe that
they can also be applied to ultrafast dynamic breast MRI sequences that are being de-
veloped102,140. This new imaging sequence allow much shorter and more cost-eﬀective
procedures, which is beneﬁcial especially for screening.
86 Summary and discussion
To summarize, in this thesis we have developed automated image analysis techniques
for breast cancer assessment in DCE-MRI of the breast. We demonstrated that the
developed methods perform well and have the potential to be incorporated in clinical
practice to facilitate reading and interpretation of DCE-MRI.
Clinical applications
In this ﬁnal section, we discuss the use in clinical practice of the algorithms developed
in this thesis in order to facilitate the analysis of breast DCE-MRI and, consequently,
improve the clinical outcome. Breast density assessment and automated detection of
breast cancer, which have been extensively described in this thesis and will be further
discussed in this section, are two clear clinical application examples. Other applica-
tions where the developed methods can serve as a tool to improve clinical workﬂow are
automatic linkage of ﬁndings across current and prior examinations43, multi-modal reg-
istration141, automated breast MRI quality assessment and pharmacokinetic modeling
calibration53, among others.
Automatic linkage of ﬁndings across current and prior examinations would allow
clinical workstations to eﬃciently deal with prior MR images. Such a system would aid
radiologists to locate suspicious areas in prior examinations. It has been shown that the
inclusion of prior MR images in breast MRI reading reduces the rate of false positives
associated with initial breast cancer MRI screening142. Similarly, registration among
diﬀerent image modalities would facilitate the interpretation and linkage of ﬁndings
across modalities. To aid in these registration tasks, the correction of intra- and inter-
patient signal intensity variability (bias ﬁeld correction and image normalization) and
the segmentation of diﬀerent structures are essential to ensure high accuracy.
Another application is automated image quality assessment. To guarantee suﬃ-
cient image quality, automated breast MRI quality controls can be incorporated during
acquisition time. This assessment would guarantee that the quality of the image is
suﬃcient to be interpreted by the radiologist. In breast MRI, motion artifacts and
parenchyma or background enhancement are the main factors that create diﬃculties
to interpret the images. Parenchyma or background enhancement refers to the en-
hancement of normal tissue due to pre-menopausal patients not being scanned during
the optimal phase of the menstrual cycle16. The presence of these eﬀects could alter
the lesion kinetic curves, which are essential to provide an accurate diagnosis. Costs
could be saved using a systematic quality assessment system. This is important as it
is known that breast MRI is a relatively expensive imaging modality, especially com-
pared to mammography or ultrasound. For instance, a breast MR scan that is clearly
aﬀected by motion artifacts could be repeated the same day. Furthermore, radiologists
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would not need to spend time analyzing bad quality images that need to be repeated
for a proper analysis. Minimum image quality criteria can be also deﬁned as required
by computer-aided detection systems. By doing so, the overall performance of a CAD
system would increase as errors related to bad quality images would be avoided. The
automated detection of these artifacts is a challenging task. The segmentation devel-
oped in this thesis could be used to segment body and breast structures in each time
point of the DCE-MRI sequence. The segmentation of these structures is required for
further processing and quantiﬁcation of large patient movements or large variations of
signal intensity along time.
A third clinical application where the developed segmentation methods can be used
is pharmacokinetic modeling calibration. Pharmacokinetic modeling oﬀers a quanti-
tative approach to describe the temporal exchange of contrast agent in a tissue of
interest. Measures such as tissue permeability and tissue vascularity, which can be
used to characterize breast lesions143, can be extracted using this approach. For a bet-
ter interpretation of contrast enhancement lesions, researchers have tried to incorporate
pharmacokinetic modeling to the interpretation of the DCE-MRI of the breast139. Some
of these models require calibrations with respect to reference tissues and make use of the
signal intensity of speciﬁc region for determining physiological measures53. In breast
MRI, the pectoral muscle, which can be automatically segmented on each scan, can
be used as a reference tissue given its properties. These pharmacokinetic modeling
methods might have the ability to produce a robust quantiﬁcation of contrast agent
concentration where factors related to the patient MR scan, such as patient weight,
administered dose and contrast medium used16, are taken into account.
Regarding the clinical applications described in this thesis, as mentioned earlier,
breast density assessment is important as risk for developing breast cancer is four times
larger in women with a breast density higher than 75%, compared to those with little or
no density7,58. In this thesis we used the developed breast density estimation algorithm
to obtain reference standard measures in MRI and validate volumetric breast density
obtained from mammography. This method could be also used for researchers who
are interested in investigating the relationship of 3-dimensional ﬁbroglandular tissue
morphology and distribution patterns with risk for developing cancer144.
Finally, computer-aided detection systems can be incorporated as a decision support
tool into clinical workﬂow. For instance, a CAD system can be used as a prompting
system to automatically marks suspicious areas during or after the ﬁrst evaluation of
the image. In this setting, the radiologist has to accept or neglect the suggested ﬁndings
of the computer. Such a system can reduce the interpretation time of analyzing breast
DCE-MRI data. Furthermore, as shown when CAD has been applied to other modal-
ities97–100, otherwise missed lesions could be detected. In breast MRI, false-negative
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diagnostic results are mainly categorized into overlooked and misinterpreted25,26,28. Re-
ported causes for observer errors are small lesion size, extensive background enhance-
ment and malignant lesions with smooth margins, which is more commonly visible in
benign disease. Although it has not been reported, it is evident that fatigue or lack of
experience while analyzing 4-dimensional data are other causes for observer error.
A cancer detection system should provide a limited number of markers, otherwise
radiologists will lose motivation to check them. In mammography and chest x-ray,
commercial CAD systems have about 1-3 marks per case135,136 and 0.5-2 marks per
image137, respectively. While we are aware that an appropriate setting for breast DCE-
MRI has to be determined using large multireader studies with a substantial amount
of normal cases to represent the screening situation, we believe that 2 false positive
per breast (4 false positives per study or volume) is acceptable as we are dealing with
volumetric data that represents both breasts in a single volume. Considering the results
achieved in this thesis, we are conﬁdent that the developed CAD system could be used
as a prompting system in screening with breast MRI. Our CAD system achieved a
sensitivity value for detection of malignant mass-like and non-mass-like lesions of 89%
at 4 false-positive ﬁndings per normal patient.
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Borstkanker is wereldwijd de meest voorkomende doodsoorzaak door kanker bij vrou-
wen1. Het vroegtijdig opsporen van borstkanker verhoogt de overlevingskans. Veel
landen hebben daarom een borstkankerscreening programma ingevoerd. In reguliere
programma’s voor borstkankerscreening worden asymptomatische vrouwen eens in de
paar jaar uitgenodigd voor het maken van een mammogram. Echter, mammograﬁe
kent beperkingen. De aanwezigheid van borstweefsel met een hoge densiteit kan de tu-
mor op de röntgenfoto namelijk vertroebelen10,58,76. Verder is er geconstateerd dat een
hoge borstdensiteit een risicofactor is voor de ontwikkeling van borstkanker10. Andere
risicofactoren zijn het voorkomen van borstkanker in de familie en de aanwezigheid van
een kiembaanmutatie van het BRCA1 of BRCA2 gen13,14.
Een benadering om deze tekortkomingen te ondervangen en de borstkankerscreening
te optimaliseren is de invoering van een gepersonaliseerde screening11. In gepersona-
liseerde borstkankerscreening programma´s worden vrouwen met een hoog risico op
het ontwikkelen van borstkanker gescreend met een complementaire modaliteit. Dy-
namic Contrast-Enhanced Magnetic Resonance (DCE-MRI) heeft potentie laten zien
als screeningsinstrument voor de populatie vrouwen met een hoog risico op het ont-
wikkelen van borstkanker17–22. In vergelijking met mammograﬁe heeft DCE-MRI een
hogere sensitiviteit, vooral bij vrouwen met een hoge borstweefsel densiteit23. MRI
is bovendien geschikt voor het opsporen van hoog gradige ductale carcinoom in situ
(DCIS), waarvan bekend is dat het zich sneller ontwikkelt tot een invasieve kanker dan
laag gradige DCIS118. Echter, het analyseren van de data is een tijdrovende taak. De
analyse van borst MRI data vereist namelijk een interpretatie van vier-dimensionaal
DCE-data, evenals de correlatie tussen multi-parametrische data van andere MRI se-
quenties. Bovendien rapporteren recente studies dat er zichtbare kankers in een voor-
gaand MRI onderzoek werden gevonden die eerder niet gezien waren of fout waren
geïnterpreteerd25,26.
Deze thesis focust zich op de automatische analyse van borst MRI. Automatische
beeldanalyse technieken en detectie systemen met behulp van een computer zijn nodig
om de klinische werkwijze te verbeteren en de radioloog te assisteren bij het lezen en
interpreteren van MRI beelden.
Hoofdstuk 2 beschrijft de ontwikkeling van twee volledig geautomatiseerde metho-
den voor de segmentatie van de pectoralis spier in borst MRI. De identiﬁcatie van
de pectoralis spier is een belangrijke stap in methoden voor automatische borstkanker
analyse. Er zijn twee mogelijke toepassingen. De eerste is het vinden van de grens
tussen het lichaam en de borst, waarbij de meest uitdagende taak het segmenteren
van de borst is door de grote verschillen tussen patiënten. De tweede methode is het
gebruik van de pectoralis spier als referentie weefsel voor farmacokinetische modellen.
De voorgestelde methoden voor de segmentatie van de pectoralis houden rekening met
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de 3-dimensionale beeldvorming van borst MRI en zijn gebaseerd op een atlas-based
methode: een probabilistische en een multi-atlas methode. Beide methoden zijn geëva-
lueerd met dezelfde dataset. De multi-atlas methode presteert iets beter dan de pro-
babilistische (respectievelijk gemiddelde DSC waardes van 0.74 ± 0.06 en 0.72 ± 0.09)
maar de computerberekeningen duurden 14 keer langer.
Hoofdstuk 3 beschrijft een automatische methode om de borst te segmenteren in
borst MRI en de borstdensiteit te schatten. Andere beeld verwerkingsmethoden om
deze taken uit te voeren worden ook in dit hoofdstuk beschreven, zoals beeld norma-
lisatie, bias-ﬁeld correctie en sternum detectie. De borst wordt gesegmenteerd door
het automatisch identiﬁceren van de grens tussen borst en lichaam en tussen borst en
achtergrond. De segmentatie van de borst en lichaam wordt uitgevoerd door gebruik
te maken van de probabilistische atlas benadering, zoals beschreven in hoofdstuk 2.
Twee-dimensionale region growing wordt toegepast om de borst van de achtergrond te
segmenteren. Vervolgens wordt het borst volume van elke borst opnieuw gedeﬁnieerd
door gebruik te maken van de detectie van de borstcurvature en herkenningspunten.
Zo worden delen met vetweefsel, die geen onderdeel vormen van de borst en niet te
zien zijn in mammogrammen, uitgesloten. Hierdoor zijn de metingen van de borstden-
siteit berekend met MRI vergelijkbaar met borstdensiteit berekend met mammograﬁe.
Tenslotte is de borstdensiteit voor elke borst onafhankelijk berekend door gebruik te
maken van Expectation-Maximization algoritme en skin-fold removal. Resultaten laten
een grote overeenkomst zien tussen automatische borst segmentatie en borstdensiteit
en handmatige segmentatie door experts. Voor borst segmentatie, bereikten we een
gemiddelde DSC waarde 0.94 ± 0.04 en een gemiddelde totale overlap van 0.96 ± 0.02.
Voor de automatische ﬁbroglandular weefsel segmentatie, bereikten we een gemiddelde
DSC waarde van 0.80 ± 0.13.
Hoofdstuk 4 beschrijft een licht bewerkte methode ten opzichte van de methode
met de borst segmentatie en berekening van de borstdensiteit beschreven in hoofd-
stuk 3. Deze methode wordt gebruikt om Volpara 1.4.3 (Mātakina, Wellington, New
Zealand) te valideren, wat een commercieel beschikbare methode is om volumetrische
borstdensiteit te meten in FFDM. Volumetrische berekeningen verkregen met Volpara
door middel van FFDM beelden werden vergeleken met volume berekeningen verkregen
met borst MRI data van dezelfde patiënt. Voor deze vergelijking werd de door ons ont-
wikkelde methode toegepast op 250 MRI-scans. Een radioloog met expertise in borst
imaging beoordeelde nauwkeurig alle slabs van de borst segmentatie en selecteerde 186
(74,4%) MRI segmentatie studies als geschikt om als referentie te gebruiken voor de
validatie van de FFDM densiteit metingen. Volumetrische borstdensiteit en volume
van borstweefsel verkregen met Volpara laten hoge correlaties zien wanneer deze wor-
den vergeleken met MRI metingen (correlatie waarden per borst en per studie van 0.91
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en 0.93, respectievelijk). Deze bevinding laat zien dat het haalbaar is om accurate
metingen te verrichten van absolute en relatieve volumes van borstweefsel van FFDM
densiteit metingen. De beschikbaarheid van deze metingen is cruciaal voor de ontwik-
keling van objectieve borstkanker modellen en kan, in plaats van de stratiﬁcatie van
vrouwen, gebruikt worden voor gepersonaliseerde borstkankerscreening protocollen.
Hoofdstuk 5 geeft een beschrijving van een Computer-Aided Detection (CAD) sys-
teem voor het automatisch opsporen van borstkanker in DCE-MRI. Het CAD systeem
corrigeert fouten veroorzaakt door beweging en segmenteert automatisch de borst. Ver-
volgens worden laesie locatie kandidaten opgespoord door gebruik te maken van rela-
tieve contrast en weefsel structuur eigenschappen zoals blob descriptors. De laatste
classiﬁcatie wordt gemaakt door gebruik te maken van region-based morfologische en
kinetische eigenschappen berekend met gesegmenteerde laesie kandidaten. De kwaliteit
van het systeem voor de opsporing van massa- en nietmassa-achtige laesies is geëva-
lueerd. Borstkanker wordt gedetecteerd met een hoge sensitiviteit bij een acceptabel
aantal fout-positieven: 0.55, 0.78, 0.89 en 0.95 bij 0.1, 1, 4 en 7 fout positieven per scan,
waarbij fout-positieven werden bepaald bij normale patiënten. Ook bleek dat correctie
voor beweging nodig is om de prestatie van het CAD-systeem te optimaliseren. De ver-
kregen resultaten zijn veelbelovend. Het systeem kan gebruikt worden als hulpmiddel
voor radiologen tijdens de analyse van DCE-MRI data door het automatisch tonen van
verdachte gebieden.
In hoofdstuk 6 onderzochten we of ons CAD systeem borstkanker kan opsporen in
de gevallen waar de radiologen bij borstkanker screening met MRI het niet hebben
ontdekt of verkeerd geïnterpreteerd hebben. Er werd een dataset van 41 paren van
DCE-MRI studies verzameld. Elk paar bestond uit een voorgaande DCE-MRI en een
follow-up DCE-MRI waarbij borstkanker werd gediagnosticeerd. In een retrospectieve
review van deze casussen vonden wij dat in 16 gevallen de borstkanker zichtbaar was
en 15 gevallen waar het minimaal zichtbaar was in de eerdere DCE-MRI scan. Ons
CAD-systeem ontdekte 63% van de zichtbare en 19% van de minimaal zichtbare laesies
bij 2 fout positieven per borst. Deze resultaten suggereren dat de integratie van dit
systeem in de klinische praktijk de radioloog kan assisteren om fouten bij het lezen te
voorkomen.
Samenvattend, in deze thesis hebben we automatische beeld analyse technieken voor
de opsporing van borstkanker ontwikkeld in DCE-MRI van de borst. We hebben laten
zien dat de ontwikkelde methoden goed presteren en de potentie hebben om geïmple-
menteerd te worden in de klinische praktijk om het lezen en interpreteren van DCE-MRI
te faciliteren.
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El càncer de mama, a nivell mundial, és la causa de mort més comuna entre les do-
nes1. Donat que la detecció precoç d’aquesta malaltia augmenta les possibilitats de
supervivència, s’han introduït en molts països programes de cribratge de càncer de
mama (o pit). En aquests programes de cribratge s’examinen de forma periòdica do-
nes asimptomàtiques mitjançant mamograﬁa digital. No obstant, la mamograﬁa té les
seves limitacions i és que els tumors poden quedar ocults per la presència de teixit
dens10,58,76. Aquest fet diﬁculta la detecció de càncer en determinats grups de pacients,
especialment en aquelles dones amb mames denses. La presència de teixit dens, o al-
trament anomenat densitat mamària, també ha estat reconegut com un factor de risc
per desenvolupar càncer de mama10. Altres factors que s’associen amb un major risc
són els antecedents familiars en aquesta malaltia i la presència de mutacions germinals
en els gens BRCA1 o BRCA2 13,14.
Per tal de superar aquestes deﬁciències i optimitzar la detecció del càncer de mama,
s’estan introduït programes de cribratge personalitzats11. En aquests programes perso-
nalitzats, s’examinen les dones amb alt risc de desenvolupar càncer de mama utilitzant
modalitats d’imatge complementàries a la mamograﬁa. La imatge de ressonància mag-
nètica, MRI (Magnetic Resonance Imaging) de l’anglès, amb seqüència dinàmica amb
agent contrast, DCE-MRI (Dynamic Contrast-Enhanced Magnetic Resonance Imaging)
de l’anglès, és una eina molt eﬁcient per a la detecció de càncer de mama en poblacions
d’alt risc. En comparació amb la mamograﬁa, DCE-MRI té una major sensibilitat17–22,
especialment en dones amb mames denses23. D’altra banda, DCE-MRI és particular-
ment útil per a la detecció de carcinomes ductals in situ, DCIS (Ductal Carcinoma
In Situ) de l’anglès, de grau elevat, els quals progressen més ràpidament cap a una
malaltia invasiva que els DCIS de grau baix118. Malauradament, l’anàlisi d’imatges de
DCE-MRI de la mama és una tasca feixuga perquè requereix la interpretació de dades
dinàmiques en quatre dimensions, així com la correlació de dades multi-paramètriques
que provenen d’altres seqüències de MRI. A més a més, estudis recents han demostrat
l’existència d’errors per part dels observadors experts a causa d’una pobra interpretació
de lesions de càncer de mama en DCE-MRI25,26.
Per optimitzar i facilitar la lectura i interpretació d’imatges DCE-MRI als radiòlegs
especialitzats calen sistemes d’ajuda assistits per ordinador per la detecció i avaluació
del càncer de mama. Amb tal ﬁnalitat, en aquesta tesi s’han estudiat i desenvolupat
noves tècniques informàtiques per l’anàlisi automatitzat d’imatges de DCE-MRI.
La identiﬁcació i la delineació de les diferents estructures visibles en la imatge, el
múscul pectoral entre elles, és essencial pels sistemes d’ajuda assistits per ordinador per
la detecció del càncer de mama. El capítol 2 es centra en el desenvolupament de dos mè-
todes totalment automatitzats per a la segmentació del múscul pectoral en DCE-MRI.
La segmentació del múscul pectoral és útil per obtenir la delimitació de la superfície
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deﬁnida entre el cos i els pits. A més a més, el múscul pectoral pot ésser utilitzat com
a teixit de referència en la modelització de paràmetres farmacocinètics. Aquests poden
aportar informació rellevant per a la classiﬁcació de lesions en lesions malignes o lesi-
ons benignes. Els mètodes de segmentació proposats en aquesta tesi tenen en compte
la naturalesa en 3 dimensions de les imatges de MRI i utilitzen informació provinent
d’atles: un mètode d’atles probabilístic i un mètode multi-atlas. Ambdós mètodes han
estat avaluats en el mateix conjunt de dades. La metodologia multi-atles va superar
lleugerament el mètode probabilístic amb valors mitjans de Dice Similarity Coeﬃcient
(DSC) de 0.74±0.06 i 0.72±0.09, respectivament, però el temps computacional va ser
14 vegades més gran.
En el capítol 3 es presenta un mètode automatitzat per segmentar la mama i esti-
mar la quantitat de teixit dens de la mateixa. Per dur a terme aquesta tasca, s’han
desenvolupat i descrit en aquest capítol altres tècniques de processament d’imatge ne-
cessaris, com la normalització i la correcció de la intensitat de la imatge, i algorismes
per a la detecció de l’estèrnum. El pit es segmenta mitjançant la identiﬁcació auto-
màtica de la superfície del múscul pectoral i la superfície de la mama. La segmentació
de la superfície del múscul pectoral es realitza utilitzant la tècnica d’atles probabilístic
explicada en el capítol 2. L’algorisme region growing s’aplica per deﬁnir la superfície
del pit. Posteriorment, per tal d’excloure àrees de teixit gras que no formen part de la
mama i que no són visibles en imatges de mamograﬁa, es redeﬁneix el volum de cada
pit emprant informació de curvatura i la posició de l’estèrnum. D’aquesta manera, les
mesures de densitat extretes de MRI són comparables a les estimacions de densitat
de la mama obtingudes en mamograﬁa. Finalment, es calcula la densitat mamària de
forma independent per a cada pit utilitzant l’algorisme Expectation-Maximization i un
algorisme d’eliminació d’artefactes produïts per plecs en la pell durant el posicionament
de la dona en l’escàner. Els resultat obtinguts mostren alta concordança entre les seg-
mentacions del pit i del teixit dens produïdes per l’algorisme proposat i les anotacions
manual realitzades per experts. Per a la segmentació de la mama, es va obtenir un
valor DSC de mitjana de 0.94 ± 0.04 i un valor de total overlap de 0.96 ± 0.02. Per a
la segmentació automàtica del teixit dens, es va obtenir un valor DSC de mitjana de
0.80 ± 0.13.
Una versió lleugerament modiﬁcada d’aquest algorisme de segmentació de pit i es-
timació de densitat mamària s’ha utilitzat en l’estudi descrit en el capítol 4. Aquest
estudi consisteix en la validació de Volpara 1.4.3 (Mātakina, Wellington, New Zealand),
que és un producte informàtic comercial per calcular mesures volumètriques de densitat
mamària en mamograﬁa digital. Les estimacions volumètriques obtingudes en imatges
de mamograﬁa utilitzant Volpara es van comparar amb les mesures volumètriques obtin-
gudes a partir de dades de MRI de la mama del mateix pacient. Per a aquest propòsit,
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es va aplicar el mètode desenvolupat en aquesta tesi a un conjunt de dades compost de
250 imatges de MRI. Un radiòleg amb experiència en càncer de pit va revisar de forma
acurada totes les segmentacions i va notiﬁcar que les segmentacions obtingudes en 186
(74.4%) casos eren apropiades per calcular mesures de densitat mamària de referència.
Es va observar que el valors volumètrics de densitat mamària calculats amb Volpara
presenten una alta correlació en comparació amb les mesures obtingudes en MRI (va-
lors de correlació per pit i per imatge de 0.91 i 0.93, respectivament). Aquesta troballa
demostra que és factible estimar de forma precisa la densitat mamària en mamograﬁa
digital. La disponibilitat d’aquest tipus de mesures és essencial per al desenvolupament
de models de risc de càncer de mama i poden ésser utilitzades per a l’estratiﬁcació de
les dones en els programes de monitorització personalitzats.
En el capítol 5 es descriu un sistema d’ajuda de detecció assistit per ordinador,
CAD (Computer-Aided Detection) de l’anglès, per detectar de forma automàtica càncer
de mama en imatges de DCE-MRI. El sistema CAD comença corregint els artefactes
produïts pel moviment del pacient durant l’adquisició de la imatge i a continuació
segmenta els pits. Posteriorment, es detecten els candidats a pertànyer a una lesió
utilitzant característiques de realç relatiu d’intensitats i característiques de textura que
inclouen descriptors de blobs. La classiﬁcació ﬁnal de cada regió candidata a lesió es
duu a terme emprant característiques morfològiques i característiques cinètiques. Amb
els experiments proposats s’estudia el rendiment del sistema CAD per a la detecció de
tot tipus de lesions de càncer de mama. Com a resultat, el sistema CAD detecta càncer
de mama a una alta sensibilitat amb un nombre acceptable de falsos positius: 0.55,
0.78, 0.89 i 0.95 a 0.1, 1, 4 i 7 falsos positius per pacient normal. També s’observa
que la correcció dels artefactes produïts pel moviment del pacient durant l’adquisició és
important per aconseguir el màxim rendiment del sistema CAD. En general, els resultat
obtinguts són prometedors i indicatius que el sistema CAD proposat pot ésser utilitzat
com a eina de suport durant l’anàlisi de dades de DCE-MRI.
Finalment, en el capítol 6, s’estudia el potencial del sistema CAD desenvolupat en
aquesta tesi per detectar lesions de càncer de mama que es van passar per alt o es van
malinterpretar en un programa de cribratge amb MRI. Per a la realització d’aquest
estudi, es van obtenir un total de 41 parells d’imatges DCE-MRI. Cada parell estava
compost per la imatge DCE-MRI on el càncer va ser detectat (d’aquí en endavant
DCE-MRI de diagnòstic) i una imatge de DCE-MRI del mateix pacient anterior a la
DCE-MRI de diagnòstic (DCE-MRI prèvia al DCE-MRI de diagnòstic) on el càncer no
va ser detectat. En una revisió de forma retrospectiva de totes les imatges de DCE-
MRI, es va trobar que 16 càncers de mama eren visibles i 15 eren mínimament visibles
en les imatges de DCE-MRI prèvies a les DCE-MRI de diagnòstic. El sistema CAD va
ser capaç de detectar 63% i 19% de les lesions que eren visibles i mínimament visibles
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de forma retrospectiva, respectivament, a 2 falsos positius per pit. Aquests resultats
suggereixen que la integració d’un sistema CAD d’aquest tipus en la pràctica clínica
pot ajudar els radiòlegs per evitar errors de lectura en la detecció de càncer de mama
en DCE-MRI.
En resum, en aquesta tesi s’han desenvolupat tècniques automatitzades d’anàlisi
d’imatge per a l’avaluació i la detecció de càncer de mama en imatges de DCE-MRI. S’ha
demostrat que els mètodes proposats ofereixen un bon rendiment. La seva integració
en la pràctica clínica podria facilitar i optimitzar la lectura i la interpretació d’imatges
DCE-MRI.
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